# Reference Intervals of Central Aortic Blood Pressure and Augmentation Index Assessed with an Oscillometric Device in Healthy Children, Adolescents, and Young Adults from Argentina

Authors: Alejandro Diaz; Yanina Zócalo; Daniel Bia; Edmundo Cabrera Fischer
Journal: International Journal of Hypertension
 (2018)

---

## Abstract

Age-related reference intervals (RIs) of central (aortic) systolic blood pressure (cSBP) and augmentation index (cAIx) obtained from large healthy population are lacking in Argentina (South America).Aims. To analyze the existence of associations among cSBP and cAIx with demographic, anthropometric, and hemodynamic parameters and to generate percentile curves and RIs adjusted to each level of age and gender and/or body height. cSBP and cAIx were measured in 1038 healthy children, adolescents, and young adults. First, we evaluated if RIs for males and females were necessary using correlation and covariate analysis. Second, mean (M) and standard deviation (SD) age-related equations were obtained for cSBP and cAIx, using parametric regression methods based on fractional polynomials. Third, age specific percentiles curves were generated. Fourth, body height specific percentiles curves were generated using a similar procedure. The obtained equations (considering age as independent variable) for all subjects (cSBP0.26 and (cAIx + 12.001)0.5) were as follows: cSBP Mean = 3.0581 + 0.2189 log(Age) − 0.001044Age; cSBP SD = −0.03919 + 0.1535 log(Age) − 0.004564Age; cAIx mean = 9.5226 − 6.1599 log(Age) + 0.1450Age; cAIx SD = 1.3880 − 0.8468 log(Age) + 0.03212Age. This study, performed in Argentinean healthy children, adolescents, and young adults with ages of 5 to 22 years, provides the first RIs and percentile curves of cSBP and cAIx. Additionally, specific body height-related cAIx percentiles are reported for the analyzed population. The RIs and percentiles contribute to the knowledge of arterial dynamic evolution along the normal aging process and the interpretation of data obtained in clinical research and daily clinical practice.


---

## Body

## 1. Introduction

The analysis and monitoring of vessels morphology and function in young people have become of major interest for both pediatricians and adult specialists in order to preserve and optimize cardiovascular health from childhood to adulthood [1]. The noninvasive assessment of arterial stiffness (AS) provides valuable information of structural and functional state of the vascular system, beyond that of the conventional blood pressure (BP) measurements [2]. For instance, increases in AS in adolescents and young adults are associated with left ventricular mass index, independently of traditional cardiovascular risk factors (CRFs) [3]. Screening for AS may be useful to identify subjects with cardiovascular risk in children, adolescents, and young adults’ populations [3].There are several parameters to assess AS being frequently used the aortic pulse wave velocity (PWV) and augmentation index (AIx) of the aorta and the brachial artery. PWV and AIx increase with the arterial aging process [4–6]. Is important to take into account the fact that PWV is widely considered a direct marker of AS [7], while the AIx is a well-known modality to express arterial wave reflections, often considered as a surrogate index of AS [6–8].Linked to AIx assessment, central (aortic) systolic blood pressure (cSBP) is a parameter that strongly reflects vascular changes of central elastic arteries compared to peripheral (brachial) BP, both in adults and children and adolescents [9, 10]. Moreover, changes in cSBP levels affect the heart, brain, and kidneys which are directly exposed to them [11].Central arterial and haemodynamic parameters (cAIx and cSBP) can be estimated noninvasively using a good number of techniques. They include Doppler ultrasound, applanation tonometry, oscillometry, and magnetic resonance imaging; all of them are associated with its own strengths and weaknesses [2, 12]. Oscillometric devices have been suggested to be especially adequate in children and adolescents, since the methodology includes the use of a simple pressure cuff and have the advantages of being relatively fast, operator independent and require minimal cooperation of the patient [13, 14].Independently of the technique or device used to assess the arterial properties, there are several gaps in the approach of cSBP and cAIx measurements [1], performed in pediatric clinical practice such as (a) what are the interval references (RIs) of cSBP and cAIx values for each measurement? And (b) do they differ by gender and/or body height?The 2016 European Society of Hypertension guidelines for the management of high BP in children and adolescents do not recommend the routine assessment of arterial parameters and cSBP, however, highlights the need to increase knowledge in the field of arterial parameters as markers of function of the vascular system [15]. Furthermore, the 2013 ESH/ESC guidelines for the management of arterial hypertension considered that cSBP can provide useful information in young patients with isolated systolic hypertension [16]. Moreover, cSBP may be especially relevant in asymptomatic children and adolescents incidentally found to have isolated systolic hypertension without target organ damage [15].Unfortunately, at present few epidemiological studies in healthy pediatric populations are available, in which RIs of cSBP and cAIx were obtained using brachial oscillometric cuff method [17, 18]. To the best of our knowledge, the largest databases of RIs of cSBP and cAIx in pediatrics come from Hungary [17] and Germany, in which the Arteriograph and Mobil-O-Graph System were respectively used [18].Considering the lack of knowledge in terms of cSBP and cAIx reference values for children, adolescents, and young adults from Argentina, our research purposes were as follows:(1) to analyze the existence of associations among cSBP and cAIx with demographic, anthropometric, and hemodynamic parameters,(2) to generate percentile curves and RIs adjusted to each level of age and (if required) gender and/or body height.


## 2. Materials and Methods

This study is part of a project started in 2014 in Tandil city (Buenos Aires Province), Argentina, aimed at investigating the prevalence of CRFs. Preliminary data obtained in this location have been previously reported [19–21]. Tandil is located 360 Km south of Buenos Aires City (37°19′08′′S-9°08′05′′W).The study protocol was approved by the Institutional Ethics Committee and was carried on in agreement with the Declaration of Helsinki and the Good Clinical Practice Guidelines. Written informed consent was obtained from the participants or authorized person.Asymptomatic children, adolescents, and young adults (5–22 years old) from the Tandil community were considered for enrolment in this study. Subjects were submitted to clinical interview, blood sampling evaluation, and anthropometric assessment, carried out in all cases by the same group of physicians. Blood samples were obtained after 9–12 hours of fasting. Glycaemia, lipid profile, and kidney functional parameters were determined. Anthropometric evaluation and a brief clinical interview allowed assessing CRFs exposure. Asymptomatic subjects included in the study met the following criteria: (1) none had history of cardiovascular, pulmonary, or renal disease; (2) normal peripheral BP at the time of examination (BP ≤ 140/90 mmHg in adults and BP < 90th percentile in subjects < 16 years old) [15]; (3) none were taking medications (antihypertensive, antihyperlipidemic, or antidiabetic drugs); (4) all included subjects had glycaemia < 6.11 mmol/L (<110 mg/dl), total blood cholesterol levels < 5.17 mmol/L (<200 mg/dl) [16], and normal serum triglycerides levels < 1.69 mmol/L (<150 mg/dl), ≤1.5 mmol/L (<130 mg/dl), and ≤1.13 mmol/L (<100 mg/dl) for subjects older than 18 years, subjects between 10 to 17 years, and children under 10 years, respectively [15, 22].Current and past smokers, diabetic, obese subjects (body mass index [BMI] ≥ 30 kg/m2 for adults or BMI ≥ 97th percentile for subjects under 18 years old), hypertensive subjects, or subjects with averaged high brachial BP levels at the time of the study were excluded. To this end, peripheral (brachial) BP measurements were obtained using fully automatic sphygmomanometers, operating on oscillometric principle (705IT, Omron Healthcare Inc., USA). Adults’ BP levels were classified following guidelines for the management of arterial hypertension [16]. Thus, hypertension was defined as peripheral systolic BP (pSBP) ≥ 140 mmHg and/or peripheral diastolic BP (pDBP) ≥ 90 mmHg. In turn, brachial BP levels in children and adolescents were categorized, taking into account sex, age, and body height, according to criteria of the American Pediatrics Association and the European Society of Hypertension report [15].


### 2.1. Augmentation Index and Blood Pressure Measurements

All measurements were performed using the Arteriogrph system (Arteriograph; TensioMed Ltd, Budapest, Hungary) after 10 minutes of rest in a quiet room with stable temperature (22±1°C). The Arteriograph system is an operator-independent noninvasive device that applies an oscillometric, occlusive technique by use of an upper-arm cuff to register brachial pressure waves.The mentioned device was used to assess simultaneously central (aortic) systolic and pulse pressure (cSBP, cPP) and peripheral (brachial) systolic, diastolic, pulse, and mean BP levels (pSBP, pDBP, pPP and MAP, resp.). The measurement procedure takes approximately 3 minutes and is operatively comparable to an automatic digital BP oscillometric measurement. In this study, the same device was used for all measurements. The working principle and the invasive validations of this method have been detailed previously [6, 23]. The method is based on the physiological fact that the early (P1) systolic pulse pressure wave of the aorta, generated by the left ventricle ejection, travels along the aorta and is reflected (P2) from the area of the aortic bifurcation. Occluding the brachial artery by pressurizing the cuff 35–40 mmHg above the actual SBP creates easily distinguished, pronounced pressure peaks in the cuff. Separated in this way, early and late systolic waves can be recorded. The time lapses between the peaks of P1 and P2 are equal to the travel time of the aortic pressure wave from the aortic root to the bifurcation and back. By halving this time and measuring the sternal notch, pubic bone distance (which is rather close to the true aortic length [24], the Ao-PWV can be calculated (Ao-PWV = jugulum-symphysis distance/transit time). Additionally, the Arteriography system calculates the brachial augmentation index (bAIx) using the formula: bAIx (%) = (P2-P1/PP) × 100. The cAIx was calculated based on invasive measurements previously reported [23], which showed a very strong linear correlation between bAIx and cAIx (R=0.94, p<0.001). These studies showed a strong and significant correlation between the invasively obtained values and oscillometrically measured cAIx, cSBP, and aortic PWV. Taking into account the influence of heart rate on cAIx [25], in each subject the mentioned index was calculated corresponding to 75 beats by minute (cAIx-HR75).


### 2.2. Data Analysis

In this research, a step-wise data analysis was done as is described in the following.First, aiming at determining whether RIs analysis for cAIx and cAIx-HR75 was necessaries, we separately assessed the degree of association (correlation) and equivalence (agreement) between cAIx and cAIx-HR75 levels, by studying potential mean and/or proportional differences (errors) between measurements and constructing limits of agreement (correlation and Bland-Altman analysis). As a first result, specific RIs for cAIx and cAIx-HR75 were defined as not necessaries. About this, both variables showed a great association (cAIx = -0.2753 + 0.9957·cAIx-HR75; R2=0.9953). However, despite a statistically significant difference between both variables (mean error = −0.3167%, p<0.0001; mean error 95% confidence interval = −0.3522% to −0.2811%; mean error standard deviation (SD) = 0.5836%, 95% confidence interval = −1.4605% to 0.8272%), the difference was not considered clinically significant, as to force the generation of RIs separately (for cAIx and cAIx-HR75).Second, we evaluated if RIs for males and females were necessary. To this end, bivariate and point-biserial correlations were done (Table2), and after that gender influence was examined before and after adjustment for cofactors (i.e., age, BP) applying covariance analysis (ANCOVA) (Table 3). ANCOVA allows comparing one variable (i.e., cSBP or cAIx) in two or more groups (i.e., males versus females) taking into account (or to correct for) variability of other variables, called covariates or cofactors. With this purpose, correlations were done to identify demographic, anthropometric (i.e., body height, body weight) and/or hemodynamic (i.e., heart rate, pSBP, and pDBP) variables that in theory could be considered as cofactors in covariate analysis. Once the variables significantly associated with cSBP and cAIx were identified, ANCOVA analysis was done adjusting for them (Table 3). With this purpose, several models (cofactors combinations) were analyzed. Always, prior to the ANCOVA test, Levene’s test for equality of variances and homogeneity of regression slopes test were performed. If Levene’s test is positive (p<0.05) then the variances in the groups are different (the groups are not homogeneous), and therefore the assumptions for ANCOVA are not met. Additionally, the interpretation of ANCOVA and the associated adjusted (or marginal) means relies on the assumption of homogeneous regression slopes for the compared groups (i.e., males and females); if this assumption is not met (p<0.05) the ANCOVA results are unreliable. After statistical analysis, as a result, generation of specific cSBP and cAIx RIs for males and females was considered as necessaries.Third, the mean value and SD age-related equations (for males and females) were obtained for cSBP and cAIx. With this purpose, parametric regression methods based on fractional polynomials (FPs), as described by Royston and Wright [26] and previously used to generate RIs for arterial parameters in the European Arterial Stiffness Collaboration Group methodological strategy [27, 28], were implemented using MedCalc Software (MedCalc, Ostend, Belgium). Briefly, fitting FPs for age specific cSBP and cAIx mean value and SD regression curves were defined using iterative procedure (generalized least squares, GLS). The obtained results enabled estimating age specific mean and SD for both parameters (cSBP and cAIx). For instance, cAIx mean equation could be cAIx = a+b∗agep+c∗ageq+⋯, where a, b, c,… are the coefficients, and p,q,… are the powers, with numbers selected from the set [−2, −1, −0.5, 0, 0.5, 1, 2, 3] estimated from the regression for the mean cAIx curve and likewise from the regression for the SD curve. Continuing the example, FPs with powers [1,2], that is, with p=1 and q=2, illustrate an equation with the form a + b∗ age + c∗age2 [26]. The residuals were used to assess the model fit, which was deemed appropriate if the scores were normally distributed, with a mean of 0 and a SD of 1, randomly scattered above and below 0 when plotted against age. The best fitted curves, considering visual and mathematical criteria (Kurtosis and Skewness coefficients), were selected. Then, using the equations obtained for mean and SD, age specific percentiles were defined using the standard normal distribution (Z) (Tables 4, 5, and 6 for cSBP and Tables 7, 8, and 9 for cAIx). Age specific 1th, 2.5th, 5th, 10th, 25th, 50th, 75th, 90th, 95th, 97.5th, and 99th percentile curves were calculated as mean cAIx + Zp ∗ SD, where Zp assumed the values of −2.3263, −1.9599, −1.6448, −1.2815, −0.6755, 0, 0.6755, 1.2815, 1.6448, 1.9599, and 2.3263, respectively. The obtained equations were as follows:(i) For all subjects (cSBP0.26 and (cAIx + 12.001)0.5),(1)cSBPMean=3.0581+0.2189log⁡Age-0.001044AgecSBPSD=-0.03919+0.1535log⁡Age-0.004564AgecAIxMean=9.5226-6.1599log⁡Age+0.1450AgecAIxSD=1.3880-0.8468log⁡Age+0.03212Age.(ii) For males (cSBP1.13 and (cAIx + 7.001)0.53), (2)cSBPMean=146.7373+5.4105log⁡Age+1.7801AgecSBPSD=-10.3739+39.2556log⁡Age-1.2532AgecAIxMean=7.4365-3.7152log⁡Age+0.05135AgecAIxSD=-1.2276+3.4356log⁡Age-0.1113Age.(iii) For females (cSBP0.26 and (cAIx + 12.001)0.66),(3)cSBPMean=2.9920+0.3501log⁡Age-0.007039AgecSBPSD=-0.07844+0.2039log⁡Age-0.005824AgecAIxMean=21.8535-18.4253log⁡Age+0.5115AgecAIxSD=3.2466-1.6274log⁡Age+0.03122Age.Finally, a similar procedure was performed to obtain cAIx RIs considering the body height (BH) [17]. The obtained equations were as follows:For males (cAIx + 7.001)0.53,(4)cAIxMean=-16.3756+13.9683log⁡BH-0.06468BHcAIxSD=-14.8123+8.6667log⁡BH-0.02016BH.For females (cAIx + 12.001)0.66,(5)cAIxMean=-46.6729+35.8589log⁡BH-0.1523BHcAIxSD=38.0202-21.0915log⁡BH+0.06424BH.In the equations detailed above, always cSBP, cAIx, Age, and BH were expressed in mmHg, %, years, and centimeters, respectively.Limit of statistical signification was considered when ap value < 0.05 was found. Calculus of the minimum sample size required was calculated taken into account a normal distribution of the covariate (age) in the sample (in a conservative way) and a 95% and 90% limit of reference and confidence interval (two sided), respectively, with a 95% and 10% reference range and relative margin of error, respectively. In this research, the minimum required sample size for RIs construction (i.e., for males or females) was 377 subjects [29].


## 2.1. Augmentation Index and Blood Pressure Measurements

All measurements were performed using the Arteriogrph system (Arteriograph; TensioMed Ltd, Budapest, Hungary) after 10 minutes of rest in a quiet room with stable temperature (22±1°C). The Arteriograph system is an operator-independent noninvasive device that applies an oscillometric, occlusive technique by use of an upper-arm cuff to register brachial pressure waves.The mentioned device was used to assess simultaneously central (aortic) systolic and pulse pressure (cSBP, cPP) and peripheral (brachial) systolic, diastolic, pulse, and mean BP levels (pSBP, pDBP, pPP and MAP, resp.). The measurement procedure takes approximately 3 minutes and is operatively comparable to an automatic digital BP oscillometric measurement. In this study, the same device was used for all measurements. The working principle and the invasive validations of this method have been detailed previously [6, 23]. The method is based on the physiological fact that the early (P1) systolic pulse pressure wave of the aorta, generated by the left ventricle ejection, travels along the aorta and is reflected (P2) from the area of the aortic bifurcation. Occluding the brachial artery by pressurizing the cuff 35–40 mmHg above the actual SBP creates easily distinguished, pronounced pressure peaks in the cuff. Separated in this way, early and late systolic waves can be recorded. The time lapses between the peaks of P1 and P2 are equal to the travel time of the aortic pressure wave from the aortic root to the bifurcation and back. By halving this time and measuring the sternal notch, pubic bone distance (which is rather close to the true aortic length [24], the Ao-PWV can be calculated (Ao-PWV = jugulum-symphysis distance/transit time). Additionally, the Arteriography system calculates the brachial augmentation index (bAIx) using the formula: bAIx (%) = (P2-P1/PP) × 100. The cAIx was calculated based on invasive measurements previously reported [23], which showed a very strong linear correlation between bAIx and cAIx (R=0.94, p<0.001). These studies showed a strong and significant correlation between the invasively obtained values and oscillometrically measured cAIx, cSBP, and aortic PWV. Taking into account the influence of heart rate on cAIx [25], in each subject the mentioned index was calculated corresponding to 75 beats by minute (cAIx-HR75).


## 2.2. Data Analysis

In this research, a step-wise data analysis was done as is described in the following.First, aiming at determining whether RIs analysis for cAIx and cAIx-HR75 was necessaries, we separately assessed the degree of association (correlation) and equivalence (agreement) between cAIx and cAIx-HR75 levels, by studying potential mean and/or proportional differences (errors) between measurements and constructing limits of agreement (correlation and Bland-Altman analysis). As a first result, specific RIs for cAIx and cAIx-HR75 were defined as not necessaries. About this, both variables showed a great association (cAIx = -0.2753 + 0.9957·cAIx-HR75; R2=0.9953). However, despite a statistically significant difference between both variables (mean error = −0.3167%, p<0.0001; mean error 95% confidence interval = −0.3522% to −0.2811%; mean error standard deviation (SD) = 0.5836%, 95% confidence interval = −1.4605% to 0.8272%), the difference was not considered clinically significant, as to force the generation of RIs separately (for cAIx and cAIx-HR75).Second, we evaluated if RIs for males and females were necessary. To this end, bivariate and point-biserial correlations were done (Table2), and after that gender influence was examined before and after adjustment for cofactors (i.e., age, BP) applying covariance analysis (ANCOVA) (Table 3). ANCOVA allows comparing one variable (i.e., cSBP or cAIx) in two or more groups (i.e., males versus females) taking into account (or to correct for) variability of other variables, called covariates or cofactors. With this purpose, correlations were done to identify demographic, anthropometric (i.e., body height, body weight) and/or hemodynamic (i.e., heart rate, pSBP, and pDBP) variables that in theory could be considered as cofactors in covariate analysis. Once the variables significantly associated with cSBP and cAIx were identified, ANCOVA analysis was done adjusting for them (Table 3). With this purpose, several models (cofactors combinations) were analyzed. Always, prior to the ANCOVA test, Levene’s test for equality of variances and homogeneity of regression slopes test were performed. If Levene’s test is positive (p<0.05) then the variances in the groups are different (the groups are not homogeneous), and therefore the assumptions for ANCOVA are not met. Additionally, the interpretation of ANCOVA and the associated adjusted (or marginal) means relies on the assumption of homogeneous regression slopes for the compared groups (i.e., males and females); if this assumption is not met (p<0.05) the ANCOVA results are unreliable. After statistical analysis, as a result, generation of specific cSBP and cAIx RIs for males and females was considered as necessaries.Third, the mean value and SD age-related equations (for males and females) were obtained for cSBP and cAIx. With this purpose, parametric regression methods based on fractional polynomials (FPs), as described by Royston and Wright [26] and previously used to generate RIs for arterial parameters in the European Arterial Stiffness Collaboration Group methodological strategy [27, 28], were implemented using MedCalc Software (MedCalc, Ostend, Belgium). Briefly, fitting FPs for age specific cSBP and cAIx mean value and SD regression curves were defined using iterative procedure (generalized least squares, GLS). The obtained results enabled estimating age specific mean and SD for both parameters (cSBP and cAIx). For instance, cAIx mean equation could be cAIx = a+b∗agep+c∗ageq+⋯, where a, b, c,… are the coefficients, and p,q,… are the powers, with numbers selected from the set [−2, −1, −0.5, 0, 0.5, 1, 2, 3] estimated from the regression for the mean cAIx curve and likewise from the regression for the SD curve. Continuing the example, FPs with powers [1,2], that is, with p=1 and q=2, illustrate an equation with the form a + b∗ age + c∗age2 [26]. The residuals were used to assess the model fit, which was deemed appropriate if the scores were normally distributed, with a mean of 0 and a SD of 1, randomly scattered above and below 0 when plotted against age. The best fitted curves, considering visual and mathematical criteria (Kurtosis and Skewness coefficients), were selected. Then, using the equations obtained for mean and SD, age specific percentiles were defined using the standard normal distribution (Z) (Tables 4, 5, and 6 for cSBP and Tables 7, 8, and 9 for cAIx). Age specific 1th, 2.5th, 5th, 10th, 25th, 50th, 75th, 90th, 95th, 97.5th, and 99th percentile curves were calculated as mean cAIx + Zp ∗ SD, where Zp assumed the values of −2.3263, −1.9599, −1.6448, −1.2815, −0.6755, 0, 0.6755, 1.2815, 1.6448, 1.9599, and 2.3263, respectively. The obtained equations were as follows:(i) For all subjects (cSBP0.26 and (cAIx + 12.001)0.5),(1)cSBPMean=3.0581+0.2189log⁡Age-0.001044AgecSBPSD=-0.03919+0.1535log⁡Age-0.004564AgecAIxMean=9.5226-6.1599log⁡Age+0.1450AgecAIxSD=1.3880-0.8468log⁡Age+0.03212Age.(ii) For males (cSBP1.13 and (cAIx + 7.001)0.53), (2)cSBPMean=146.7373+5.4105log⁡Age+1.7801AgecSBPSD=-10.3739+39.2556log⁡Age-1.2532AgecAIxMean=7.4365-3.7152log⁡Age+0.05135AgecAIxSD=-1.2276+3.4356log⁡Age-0.1113Age.(iii) For females (cSBP0.26 and (cAIx + 12.001)0.66),(3)cSBPMean=2.9920+0.3501log⁡Age-0.007039AgecSBPSD=-0.07844+0.2039log⁡Age-0.005824AgecAIxMean=21.8535-18.4253log⁡Age+0.5115AgecAIxSD=3.2466-1.6274log⁡Age+0.03122Age.Finally, a similar procedure was performed to obtain cAIx RIs considering the body height (BH) [17]. The obtained equations were as follows:For males (cAIx + 7.001)0.53,(4)cAIxMean=-16.3756+13.9683log⁡BH-0.06468BHcAIxSD=-14.8123+8.6667log⁡BH-0.02016BH.For females (cAIx + 12.001)0.66,(5)cAIxMean=-46.6729+35.8589log⁡BH-0.1523BHcAIxSD=38.0202-21.0915log⁡BH+0.06424BH.In the equations detailed above, always cSBP, cAIx, Age, and BH were expressed in mmHg, %, years, and centimeters, respectively.Limit of statistical signification was considered when ap value < 0.05 was found. Calculus of the minimum sample size required was calculated taken into account a normal distribution of the covariate (age) in the sample (in a conservative way) and a 95% and 90% limit of reference and confidence interval (two sided), respectively, with a 95% and 10% reference range and relative margin of error, respectively. In this research, the minimum required sample size for RIs construction (i.e., for males or females) was 377 subjects [29].


## 3. Results

### 3.1. General Characteristics of the Analyzed Population

In this research 1038 healthy subjects (576 males and 462 females) were included. In Table1 the characteristics of all children, adolescents, and young adults are summarized, discriminating values obtained for males and females. Mean age for the whole population was 15.35±3.15 years (range 5.00–21.92 y.o.) and no significant age differences were found (Table 1). In this cohort, males showed the highest body weight, body height, and BMI values (p<0.001). Also, males exhibit significant higher jugulum-symphysis distance than females (p<0.001). Mean values of pSBP and pPP obtained in males were significantly higher than those obtained in females (p<0.001); on the contrary pDBP and HR were significantly lower in males compared with females. No significant differences related to gender in terms of pMAP values were observed. Moreover, males have higher mean values of cSBP and cPP than females (p<0.05 and p<0.001, resp.). See Table 1.Table 1
Children and adolescents characteristics.
All (1038) Male (n=576) Female (n=462) p value (male versus female) MV SD Min Max MV SD Min Max MV SD Min Max Age (years) 15.35 3.15 5.00 21.92 15.51 2.84 5.00 21.75 15.15 3.49 5.17 21.92 0.068 Body height (cm) 162.67 13.98 102.00 191.00 167.15 13.72 104.00 191.00 157.09 12.20 102.00 178.00 <0.001 Body weight (Kg) 57.00 14.14 15.00 96.00 61.39 14.70 15.00 96.00 51.51 11.22 18.00 75.00 <0.001 BMI (Kg./m2) 21.17 3.11 7.90 29.40 21.60 3.14 13.60 29.40 20.64 2.98 7.90 27.82 <0.001 Jugulo -symphysis distance (cm) 47.48 4.96 28.00 74.00 49.13 4.87 28.00 74.00 45.44 4.27 28.00 56.00 <0.001 Heart rate (b.p.m.) 68.43 12.17 44.00 113.00 65.49 11.83 44.00 104.00 72.09 11.60 44.00 113.00 <0.001 Peripheral SBP (mmHg) 111.81 9.58 81.00 135.00 114.01 9.64 89.00 135.00 109.06 8.78 81.00 134.00 <0.001 Peripheral MBP (mmHg) 79.07 7.49 8.00 102.00 79.24 7.68 8.00 98.00 78.86 7.25 61.00 102.00 0.412 Peripheral DBP (mmHg) 62.71 7.51 3.00 89.00 61.97 7.17 36.00 82.00 63.63 7.84 3.00 89.00 <0.001 Peripheral PP (mmHg) 48.96 8.29 .49 86.00 51.99 8.12 31.00 86.00 45.17 6.81 .49 70.00 <0.001 Central (aortic) SBP (mmHg) 98.86 8.39 75.20 124.90 99.35 8.40 78.00 124.90 98.24 8.36 75.20 121.00 0.035 Central (aortic) PP (mmHg) 36.26 5.88 21.80 62.90 37.43 5.72 21.80 62.90 34.78 5.75 23.20 58.60 <0.001 Peripheral (brachial) AIx (%) - 1.34 7.01 - 85.00 . 60 - 1.64 8.12 - 85.00 . 29 - . 96 5.31 - 84.00 .60 0.122 cAIx (%) 9.20 8.46 - 12.00 45.90 6.67 7.40 - 7.00 36.00 12.35 8.64 - 12.00 45.90 <0.001 cAIx HR75 (%) 9.51 8.49 - 12.34 45.61 7.12 7.45 - 7.82 36.53 12.49 8.76 - 12.34 45.61 <0.001 Return time (ms) 173.47 21.17 14.00 310.00 178.91 19.43 85.00 230.00 166.68 21.32 14.00 310.00 <0.001 Ejection duration (ms) 299.06 22.73 185.00 385.00 297.90 21.09 185.00 360.00 300.49 24.59 190.00 385.00 0.068 Ao-PWV (m/s) 5.50 .63 3.40 7.70 5.51 .64 3.40 7.70 5.48 .62 3.90 7.70 0.607 BMI: body mass index. SBP, MBP, DBP, and PP: systolic, mean, diastolic, and pulse blood pressure, respectively. AIx: augmentation index. cAIx and cAIx HR75: central (aortic) augmentation index net value and normalized for heart rate equal 75 beats/minute, respectively. Ao-PWV: Aortic pulse wave velocity. Min and Max: minimal and maximal value, respectively. Ap<0.05 was considered statistically significant.Table 2
Association between aortic characteristics and anthropometric and haemodynamic parameters.
Central (aortic) SBP (mmHg) cAIx (%) Age (years) Sex (0: male; 1: female) R - . 066 . 334 - . 057 P . 035 . 000 . 068 Age (years) R . 263 - . 188 1.000 P . 000 . 000 . 000 Body height (cm) R . 238 - . 371 . 678 P . 000 . 000 . 000 Body weight (Kg) R . 318 - . 362 . 617 P . 000 . 000 . 000 BMI (Kg/m2) R . 320 - . 215 . 414 P . 000 . 000 . 000 Yugulo-symphysis distance (cm) R . 242 - . 378 . 656 P . 000 . 000 . 000 Heart rate (b.p.m.) R . 054 . 005 - . 358 P . 079 . 881 . 000 Peripheral SBP (mmHg) R . 892 - . 216 . 308 P . 000 . 000 . 000 Peripheral MBP (mmHg) R . 863 - . 016 . 293 P . 000 . 617 . 000 Peripheral DBP (mmHg) R . 720 . 107 . 236 P . 000 . 001 . 000 Peripheral PP (mmHg) R . 385 - . 336 . 131 P . 000 . 000 . 000 Central (aortic) SBP (mmHg) R 1.000 . 164 . 263 P . 000 . 000 . 000 Central (aortic) PP (mmHg) R . 525 . 180 . 040 P . 000 . 000 . 202 Peripheral (brachial) AIx R - . 018 . 079 - . 079 P . 571 . 011 . 011 cAIx (%) R . 164 1.000 - . 188 P . 000 . 000 . 000 cAIx HR75 (%) R . 162 . 997 - . 160 P . 000 . 000 . 000 Ejection duration (ms) R - . 026 . 207 . 096 P . 396 . 000 . 002 Return time (ms) R - . 118 - . 327 . 152 P . 000 . 000 . 000 Ao-PWV (m/s) R . 374 . 010 . 456 P . 000 . 757 . 000 BMI: body mass index. SBP, MBP, DBP, and PP: systolic, mean, diastolic, and pulse blood pressure, respectively. AIx: augmentation index. cAIx and cAIx HR75: central (aortic) augmentation index net value and normalized for heart rate equal 75 beats/minute, respectively. Ao-PWV: aortic pulse wave velocity. Ap<0.05 was considered statistically significant.Table 3
Sex-related cSBP and cAIx comparison: analysis of covariance (ANCOVA) adjusting by age, heart rate, and/or anthropometric variables (cofactors).
(a) cSBP (mMHg): before adjustment cSBP (mmHg): after adjustment by covariates Covariates appearing in the model are evaluated at the following values Levene’s test Homogeneity of regression slopes test AdjustedR2 MV SD p MV SE 95% CI lower bound 95% CI upper bound p Age (years) Body height (cm) Body weight (Kg) Yugulo-Symphysis distance (cm) Heart rate (b.p.m.) Model 1 Male 99.3517 8.39824 <0.001 99.241 .337 98.579 99.903 0.090 15.35 ------ ------ ------ ------ 0.773 0.002 0.070 Female 98.2448 8.35555 98.383 .377 97.643 99.122 Model 2 Male 99.3517 8.39824 <0.001 98.813 .350 98.125 99.500 0.852 15.35 162.67 57.00 47.48 ------ 0.797 0.011 0.113 Female 98.2448 8.35555 98.917 .397 98.139 99.696 Model 3 Male 99.3517 8.39824 <0.001 99.616 .337 98.954 100.278 0.724 15.35 ------ ------ ------ 68.43 0.724 0.001 0.101 Female 98.2448 8.35555 97.916 .378 97.173 98.658 Model 4 Male 99.3517 8.39824 <0.001 99.061 .345 98.385 99.737 0.415 15.35 162.67 57.00 47.48 68.43 0.859 0.005 0.151 Female 98.2448 8.35555 98.607 .391 97.841 99.374  (b) cAIx: before adjustment cAIx: after adjustment by covariates Covariates appearing in the model are evaluated at the following values Levene’s test Homogeneity of regression slopes test AdjustedR2 MV SD p MV SE 95% CI lower bound 95% CI upper bound p Age (years) Body Height (cm) Body weight (Kg) Yugulo-Symphysis distance (cm) Heart rate (b.p.m.) Model 1 Male 6.6737 7.40231 <0.001 6.747 .327 6.104 7.389 <0.001 15.35 ------ ------ ------ ------ <0.001 0.228 0.138 Female 12.3474 8.64323 12.257 .366 11.539 12.974 Model 2 Male 6.6737 7.40231 <0.001 7.72 .337 7.059 8.380 <0.001 15.35 162.67 57.00 47.4846 ------ <0.001 0.158 0.193 Female 12.3474 8.64323 11.043 .381 10.295 11.792 Model 3 Male 6.6737 7.40231 <0.001 6.411 .328 5.767 7.055 <0.001 15.35 ------ ------ ------ 68.43 0.020 0.008 0.163 Female 12.3474 8.64323 12.675 .368 11.953 13.397 Model 4 Male 6.6737 7.40231 <0.001 7.447 .329 6.802 8.093 <0.001 15.35 162.67 57.00 47.4846 68.43 0.005 0.006 0.238 Female 12.3474 8.64323 11.383 .373 10.651 12.115 cSBP: central (aortic) systolic blood pressure. MV: mean value: SD and SE: standard deviation and error, respectively. CI: confidence interval. cAIx: central (aortic) augmentation index (net value). Ap<0.05 was considered statistically significant.Table 4
Age-related reference intervals (RIs) for central (aortic) systolic blood pressure for the entire population (n=1038).
Age (years) 1th 2.5th 5th 10th 25th 50th 75th 90th 95th 97.5th 99th 5.0 77.6 79.2 80.7 82.3 85.1 88.3 91.6 94.6 96.5 98.1 100.0 6.0 77.5 79.4 81.0 83.0 86.3 90.0 93.9 97.5 99.7 101.7 104.0 7.0 77.5 79.6 81.5 83.6 87.3 91.5 95.9 99.9 102.4 104.6 107.2 8.0 77.7 79.9 81.9 84.2 88.2 92.8 97.5 102.0 104.7 107.1 109.9 9.0 77.9 80.3 82.4 84.8 89.0 93.9 99.0 103.7 106.6 109.1 112.2 10.0 78.2 80.7 82.9 85.4 89.8 94.9 100.2 105.1 108.2 110.8 114.0 11.0 78.6 81.2 83.4 86.0 90.5 95.8 101.3 106.4 109.5 112.3 115.6 12.0 79.0 81.6 83.9 86.6 91.2 96.6 102.2 107.4 110.7 113.5 116.9 13.0 79.5 82.1 84.5 87.2 91.9 97.4 103.1 108.4 111.7 114.6 118.0 14.0 80.0 82.7 85.0 87.8 92.5 98.0 103.8 109.2 112.5 115.4 118.9 15.0 80.5 83.2 85.6 88.3 93.1 98.7 104.5 109.9 113.2 116.2 119.7 16.0 81.1 83.8 86.1 88.9 93.7 99.3 105.1 110.5 113.8 116.7 120.3 17.0 81.7 84.4 86.7 89.5 94.3 99.8 105.6 111.0 114.3 117.2 120.7 18.0 82.3 85.0 87.3 90.1 94.8 100.3 106.0 111.4 114.7 117.6 121.1 19.0 83.0 85.6 87.9 90.6 95.3 100.8 106.5 111.8 115.0 117.9 121.3 20.0 83.6 86.2 88.5 91.2 95.9 101.2 106.8 112.1 115.3 118.1 121.5 21.0 84.3 86.9 89.1 91.8 96.4 101.7 107.2 112.3 115.5 118.2 121.6 21.8 84.8 87.4 89.6 92.3 96.8 102.0 107.4 112.5 115.6 118.3 121.6Table 5
Age-related reference intervals (RIs) for central (aortic) systolic blood pressure for males (n=576).
Age (years) 1th 2.5th 5th 10th 25th 50th 75th 90th 95th 97.5th 99th 5.0 76.4 78.4 80.1 82.1 85.3 89.0 92.5 95.8 97.7 99.3 101.2 6.0 75.4 77.7 79.7 82.0 85.8 90.0 94.2 98.0 100.2 102.2 104.4 7.0 74.8 77.4 79.6 82.2 86.4 91.1 95.7 99.9 102.4 104.5 107.0 8.0 74.7 77.5 79.8 82.6 87.1 92.1 97.1 101.5 104.2 106.5 109.1 9.0 74.8 77.8 80.3 83.1 87.9 93.1 98.4 103.0 105.8 108.2 111.0 10.0 75.2 78.2 80.8 83.8 88.7 94.1 99.5 104.3 107.2 109.7 112.6 11.0 75.8 78.9 81.5 84.5 89.6 95.1 100.6 105.5 108.5 111.0 113.9 12.0 76.5 79.6 82.3 85.4 90.5 96.1 101.7 106.6 109.6 112.2 115.1 13.0 77.4 80.5 83.2 86.3 91.4 97.0 102.7 107.6 110.6 113.2 116.2 14.0 78.4 81.5 84.2 87.3 92.4 98.0 103.6 108.6 111.6 114.2 117.1 15.0 79.4 82.5 85.2 88.3 93.3 98.9 104.5 109.5 112.4 115.0 118.0 16.0 80.6 83.6 86.3 89.3 94.3 99.9 105.4 110.3 113.2 115.8 118.7 17.0 81.8 84.8 87.4 90.4 95.3 100.8 106.3 111.1 114.0 116.5 119.4 18.0 83.1 86.0 88.6 91.5 96.4 101.7 107.1 111.9 114.7 117.1 120.0 19.0 84.4 87.3 89.8 92.7 97.4 102.7 107.9 112.6 115.3 117.7 120.5 20.0 85.8 88.6 91.0 93.8 98.5 103.6 108.7 113.2 116.0 118.3 121.0 21.0 87.2 90.0 92.3 95.0 99.5 104.5 109.5 113.9 116.5 118.8 121.5 21.6 88.1 90.8 93.1 95.8 100.2 105.1 109.9 114.3 116.9 119.1 121.7Table 6
Age-related reference intervals (RIs) for central (aortic) systolic blood pressure for females (n=462).
Age (years) 1th 2.5th 5th 10th 25th 50th 75th 90th 95th 97.5th 99th 5.2 79.5 80.8 82.0 83.4 85.7 88.3 91.0 93.5 95.0 96.3 97.9 6.0 79.2 80.9 82.3 84.0 86.8 90.0 93.4 96.4 98.3 100.0 101.9 7.0 79.1 81.0 82.6 84.6 88.0 91.8 95.8 99.5 101.7 103.7 106.0 8.0 79.0 81.1 83.0 85.2 88.9 93.3 97.8 101.9 104.5 106.7 109.4 9.0 79.0 81.3 83.3 85.7 89.8 94.5 99.4 103.9 106.7 109.2 112.1 10.0 79.1 81.5 83.7 86.2 90.5 95.5 100.7 105.5 108.5 111.1 114.3 11.0 79.2 81.7 84.0 86.6 91.1 96.3 101.8 106.8 110.0 112.7 116.0 12.0 79.4 82.0 84.3 87.0 91.6 97.0 102.6 107.9 111.1 114.0 117.4 13.0 79.6 82.3 84.6 87.4 92.1 97.6 103.4 108.7 112.0 115.0 118.5 14.0 79.9 82.5 84.9 87.7 92.5 98.1 103.9 109.4 112.7 115.7 119.2 15.0 80.1 82.8 85.2 88.0 92.9 98.5 104.4 109.8 113.2 116.2 119.8 16.0 80.4 83.1 85.5 88.3 93.2 98.8 104.7 110.2 113.6 116.6 120.1 17.0 80.7 83.4 85.8 88.6 93.5 99.1 104.9 110.4 113.7 116.7 120.3 18.0 81.1 83.8 86.1 88.9 93.7 99.2 105.0 110.4 113.8 116.7 120.3 19.0 81.4 84.1 86.4 89.2 93.9 99.4 105.1 110.4 113.7 116.6 120.1 20.0 81.8 84.4 86.7 89.4 94.1 99.5 105.1 110.3 113.6 116.4 119.8 21.0 82.2 84.8 87.0 89.7 94.2 99.5 105.0 110.1 113.3 116.1 119.4 21.8 82.5 85.1 87.3 89.9 94.3 99.5 104.9 109.9 113.0 115.7 119.0Table 7
Age-related reference intervals (RIs) for central (aortic) augmentation index (cAIx) for the entire population (n=1038).
Age (years) 1th 2.5th 5th 10th 25th 50th 75th 90th 95th 97.5th 99th 5.0 1.8 4.5 7.1 10.2 16.0 23.3 31.4 39.4 44.5 49.1 54.7 6.0 - 0.1 2.4 4.7 7.5 12.8 19.3 26.7 34.0 38.6 42.8 48.0 7.0 - 1.5 0.8 2.9 5.5 10.3 16.4 23.3 30.0 34.3 38.3 43.0 8.0 - 2.6 - 0.5 1.5 3.9 8.5 14.2 20.6 27.0 31.1 34.8 39.4 9.0 - 3.4 - 1.5 0.4 2.7 7.0 12.5 18.7 24.8 28.7 32.3 36.6 10.0 - 4.1 - 2.3 - 0.5 1.7 5.9 11.2 17.1 23.0 26.8 30.3 34.5 11.0 - 4.7 - 2.9 - 1.2 1.0 5.0 10.1 15.9 21.7 25.4 28.8 32.9 12.0 - 5.2 - 3.4 - 1.8 0.3 4.3 9.3 15.0 20.7 24.3 27.7 31.7 13.0 - 5.6 - 3.8 - 2.2 - 0.2 3.7 8.7 14.3 19.9 23.6 26.9 30.9 14.0 - 5.9 - 4.2 - 2.6 - 0.6 3.3 8.2 13.8 19.4 23.0 26.3 30.4 15.0 - 6.1 - 4.5 - 2.9 - 0.9 2.9 7.8 13.4 19.1 22.7 26.0 30.1 16.0 - 6.4 - 4.7 - 3.2 - 1.1 2.7 7.6 13.2 18.9 22.5 25.9 30.0 17.0 - 6.6 - 4.9 - 3.4 - 1.3 2.5 7.4 13.1 18.8 22.5 25.9 30.0 18.0 - 6.7 - 5.1 - 3.5 - 1.5 2.4 7.4 13.1 18.9 22.6 26.1 30.3 19.0 - 6.8 - 5.2 - 3.6 - 1.6 2.3 7.4 13.2 19.1 22.9 26.4 30.6 20.0 - 6.9 - 5.3 - 3.7 - 1.6 2.3 7.4 13.4 19.3 23.2 26.8 31.1 21.0 - 7.0 - 5.4 - 3.8 - 1.7 2.3 7.6 13.6 19.7 23.7 27.3 31.8 21.8 - 7.1 - 5.4 - 3.8 - 1.7 2.4 7.7 13.8 20.1 24.1 27.8 32.3Table 8
Age-related reference intervals (RIs) for central (aortic) augmentation index (cAIx) for males (n=576).
Age (years) 1th 2.5th 5th 10th 25th 50th 75th 90th 95th 97.5th 99th 5.0 4.6 6.0 7.2 8.7 11.4 14.6 18.1 21.4 23.4 25.3 27.5 6.0 1.2 2.7 4.1 5.8 8.9 12.7 16.9 21.0 23.6 26.0 28.8 7.0 - 1.1 0.4 1.9 3.7 7.0 11.2 15.9 20.6 23.6 26.3 29.6 8.0 - 2.6 - 1.1 0.3 2.1 5.6 10.0 15.1 20.2 23.4 26.4 30.0 9.0 - 3.6 - 2.2 - 0.8 1.0 4.5 9.0 14.3 19.7 23.1 26.3 30.2 10.0 - 4.3 - 3.0 - 1.6 0.1 3.6 8.2 13.6 19.1 22.7 26.0 30.0 11.0 - 4.8 - 3.6 - 2.3 - 0.5 2.9 7.5 13.0 18.6 22.2 25.6 29.7 12.0 - 5.2 - 4.0 - 2.7 - 1.0 2.4 7.0 12.4 18.0 21.7 25.1 29.2 13.0 - 5.4 - 4.3 - 3.1 - 1.4 1.9 6.5 11.9 17.5 21.1 24.5 28.7 14.0 - 5.6 - 4.5 - 3.3 - 1.7 1.6 6.0 11.4 16.9 20.5 23.8 27.9 15.0 - 5.6 - 4.6 - 3.5 - 1.9 1.3 5.6 10.9 16.3 19.8 23.1 27.2 16.0 - 5.7 - 4.7 - 3.5 - 2.0 1.1 5.3 10.4 15.7 19.2 22.4 26.3 17.0 - 5.7 - 4.7 - 3.6 - 2.1 0.9 5.0 10.0 15.1 18.5 21.6 25.4 18.0 - 5.6 - 4.6 - 3.6 - 2.1 0.8 4.8 9.6 14.5 17.7 20.7 24.4 19.0 - 5.6 - 4.6 - 3.5 - 2.1 0.7 4.6 9.2 13.9 17.0 19.9 23.4 20.0 - 5.4 - 4.5 - 3.4 - 2.1 0.7 4.4 8.8 13.3 16.3 19.0 22.3 21.0 - 5.3 - 4.3 - 3.3 - 2.0 0.7 4.2 8.4 12.7 15.5 18.1 21.3 21.6 - 5.2 - 4.2 - 3.2 - 1.9 0.7 4.1 8.2 12.4 15.1 17.6 20.6Table 9
Age-related reference intervals (RIs) for central (aortic) augmentation index (cAIx) for females (n=462).
Age (years) 1th 2.5th 5th 10th 25th 50th 75th 90th 95th 97.5th 99th 5.2 3.5 6.8 9.7 13.3 19.8 27.5 35.8 43.7 48.6 53.0 58.2 6.0 1.4 4.4 7.2 10.5 16.5 23.7 31.4 38.8 43.4 47.5 52.4 7.0 - 0.5 2.2 4.8 7.8 13.4 20.1 27.3 34.1 38.4 42.3 46.8 8.0 - 1.9 0.6 3.0 5.9 11.1 17.4 24.1 30.6 34.7 38.3 42.6 9.0 - 2.9 - 0.5 1.7 4.4 9.3 15.3 21.8 28.0 31.8 35.3 39.4 10.0 - 3.7 - 1.4 0.7 3.4 8.1 13.8 20.0 25.9 29.6 33.0 36.9 11.0 - 4.2 - 2.0 0.1 2.6 7.1 12.7 18.6 24.4 28.0 31.2 35.0 12.0 - 4.5 - 2.4 - 0.4 2.0 6.4 11.8 17.7 23.2 26.7 29.9 33.6 13.0 - 4.7 - 2.7 - 0.7 1.7 6.0 11.3 17.0 22.4 25.9 28.9 32.6 14.0 - 4.8 - 2.8 - 0.9 1.5 5.7 10.9 16.5 21.9 25.2 28.3 31.9 15.0 - 4.8 - 2.8 - 0.9 1.4 5.6 10.7 16.3 21.6 24.9 27.9 31.4 16.0 - 4.8 - 2.7 - 0.8 1.5 5.6 10.7 16.2 21.4 24.7 27.7 31.2 17.0 - 4.6 - 2.6 - 0.7 1.6 5.8 10.8 16.3 21.5 24.8 27.7 31.2 18.0 - 4.4 - 2.3 - 0.5 1.9 6.0 11.0 16.5 21.7 25.0 27.9 31.4 19.0 - 4.1 - 2.0 - 0.1 2.2 6.3 11.4 16.8 22.1 25.3 28.2 31.7 20.0 - 3.7 - 1.7 0.3 2.6 6.8 11.8 17.3 22.5 25.8 28.7 32.2 21.0 - 3.3 - 1.2 0.7 3.1 7.3 12.4 17.9 23.1 26.4 29.3 32.8 21.8 - 3.0 - 0.8 1.1 3.5 7.7 12.9 18.4 23.7 27.0 29.9 33.4No significant gender differences in peripheral AIx, ejection duration, and Ao-PWV mean values were observed in the analyzed population. Obtained mean values of cAIx and cAIx-HR75 were always higher in females than in males (p<0.001). See Table 1.


### 3.2. Analysis of cSBP and cAIx Associations

As was mentioned significant differences between cAIx and cAIx-HR75 were found; however absolutely values of these differences were really minimal (mean error = −0.3167,p<0.0001; mean error 95% confidence interval = −0.3522 to −0.2811; mean error SD = 0.5836, 95% confidence interval = −1.4605 to 0.8272). Consequently, taking into account the RIs generated in terms of cAIx, it was evidenced that it was not necessary to generate RIs using cAIx-HR75 obtained values. That is to say, percentiles generated using cAIx or cAIx-HR75 were very similar and observed differences were lack of clinical relevance. In other words, the difference was not considered clinically significant, as to force the generation of RIs separately (for cAIx and cAIx-HR75).Table2 show the bivariate and point-biserial correlation study of cSBP, cAIx, and Age relationship with demographic, anthropometric, hemodynamic, and vascular parameters of the analyzed population. As can be seen in Table 2, the age and the anthropometric parameters show a positive and significantly association with cSBP and cAIx levels. Moreover, HR shows borderline statistic values of association with cSBP (p=0.079).Table3 show a covariance (ANCOVA) study destined to determine if the gender discrimination would be necessary in the RIs of cSBP and cAIx generation using data collected in this research. Also in Table 3, the noncorrected and corrected marginals’ means values with standard error and 95% confidence intervals are given for males and females. In the case of cSPB, a first analysis induces to think that adjustments using Models 1, 2, 3, and 4 show no statistically significantly gender differences. However, the comparison of regression lines obtained from males and females showed statistically significant differences; that is to say there are different slopes of the cSBP-age regression lines (see homogeneity of regression slope’s test in Table 3(a)). As the ANCOVA analysis and the associated adjusted means values rely on the assumption of the homogeneity of regression slopes in the studied groups. If this assumption is not met (p<0.05) the ANCOVA results are unreliable; consequently, in the analyzed population, it is absolutely necessary to perform different RIs for cSBP for males and females (Table 3(a)). Similar results were obtained when sex-related differences in cAIx were analyzed using Models 3 and 4 (Table 3(b)). Moreover, for all considered models, sex-related differences after Levene’s test for equality of variances were also demonstrated (different in terms of the calculated variance). Again, if Levene’s test is positive (p<0.05) the variances in the analyzed groups should be considered statistically different (the groups are not homogeneous); so the assumption of homogeneity is not met and the ANCOVA analysis is invalid. As a consequence of the results obtained in cAIx ANCOVA analysis, sex-related RIs should be necessary in this population (Table 3(b)).


### 3.3. Reference Intervals (Percentile Analysis) Obtained in the Analyzed Population

As is shown in Table4, specific percentiles of age-cSBP values for five-year age RIs were generated including the entire population (n=1038), that is, including males and females. Furthermore, a similar analysis was carried out using values corresponding to each year of age (Table A in Supplementary Materials). As seen in Table 5, age-cSBP percentiles corresponding to 5-year age intervals were generated for males (n=576). A similar analysis was done for each year of age, as seen in Table B (see Supplementary Materials). Females (n=462) were analyzed using a similar method, and the obtained RIs can be seen in Table 6 and Table C (see Supplementary Materials). Figures 1(a), 1(b), and 1(c) show specific age-cSBP percentiles for the entire population, males and females, respectively. As expected, there was a positive association between age and cSBP values, representing a gradual and continuous increase in terms of cSBP.Figure 1 (a)
Age specific central (aortic) systolic blood pressure (cSBP) percentiles generated using data of the entire population (n=1038) of children and adolescents (b)
Age specific central (aortic) systolic blood pressure (cSBP) percentiles corresponding to male cohort (n=576) of children and adolescents (c)
Age specific central (aortic) systolic blood pressure (cSBP) percentiles corresponding to female cohort (n=462) of children and adolescentsTables7, 8, and 9 show specific percentiles of age-cAIx values for five-year age RIs corresponding to the entire population, males and females, respectively. Furthermore, a similar analysis was carried out using values obtained by each year of age (Tables D, E, and F in Supplementary Materials). Figures 2(a), 2(b), and 2(c) show specific age-cAIx percentiles for the entire population, males and females, respectively. As expected, there was a correlation between age and cAIx values.Figure 2 (a)
Age specific central (aortic) augmentation index (cAIx) percentiles generated using data of the entire population (n=1038) of children and adolescents (b)
Age specific central (aortic) augmentation index (cAIx) percentiles corresponding to male cohort (n=576) of children and adolescents (c)
Age specific central (aortic) augmentation index (cAIx) percentiles corresponding to female cohort (n=462) of children and adolescentsSpecific percentile analysis of cAIx corresponding to each body height level (using 5 cm intervals) of the male cohort is shown in Table10. Also in Table G, using 1 cm interval is provided in Supplementary Materials. Furthermore, in Table 11 and Table H of the Supplementary Materials, RIs corresponding to the female cohort are showed. Figures 3(a) and 3(b) show body height-cAIx percentiles, corresponding to males and females, respectively.Table 10
Body height-related reference intervals (RIs) for central (aortic) augmentation index (cAIx) for males (n=576).
Body height (cm) 1th 2.5th 5th 10th 25th 50th 75th 90th 95th 97.5th 99th 104 5.06 6.36 7.54 8.95 11.43 14.41 17.59 20.62 22.51 24.20 26.23 105 4.79 6.12 7.32 8.76 11.31 14.35 17.62 20.74 22.69 24.44 26.52 110 3.54 4.97 6.26 7.83 10.64 14.03 17.70 21.23 23.45 25.44 27.83 115 2.38 3.87 5.24 6.91 9.93 13.61 17.63 21.52 23.98 26.19 28.85 120 1.31 2.85 4.26 6.01 9.18 13.10 17.41 21.61 24.28 26.69 29.59 125 0.33 1.88 3.33 5.12 8.41 12.52 17.07 21.54 24.39 26.96 30.08 130 - 0.58 0.97 2.43 4.25 7.62 11.87 16.62 21.31 24.31 27.03 30.32 135 - 1.41 0.11 1.57 3.40 6.82 11.17 16.07 20.93 24.06 26.89 30.33 140 - 2.18 - 0.69 0.75 2.57 6.01 10.42 15.43 20.43 23.65 26.58 30.14 145 - 2.88 - 1.44 - 0.03 1.76 5.19 9.63 14.71 19.80 23.09 26.09 29.75 150 - 3.51 - 2.13 - 0.77 0.99 4.37 8.81 13.91 19.07 22.41 25.46 29.18 155 - 4.09 - 2.78 - 1.48 0.23 3.56 7.96 13.06 18.24 21.61 24.69 28.46 160 - 4.61 - 3.38 - 2.14 - 0.49 2.76 7.09 12.16 17.33 20.70 23.79 27.58 165 - 5.07 - 3.93 - 2.76 - 1.18 1.96 6.21 11.21 16.34 19.70 22.79 26.57 170 - 5.49 - 4.44 - 3.34 - 1.84 1.19 5.32 10.23 15.30 18.62 21.68 25.44 175 - 5.85 - 4.90 - 3.88 - 2.47 0.43 4.43 9.23 14.20 17.47 20.50 24.21 180 - 6.16 - 5.31 - 4.38 - 3.06 - 0.31 3.54 8.20 13.06 16.27 19.24 22.89 185 - 6.42 - 5.68 - 4.83 - 3.61 - 1.02 2.66 7.16 11.88 15.02 17.91 21.50 190 - 6.63 - 6.01 - 5.25 - 4.13 - 1.71 1.80 6.12 10.68 13.72 16.54 20.03 191 - 6.67 - 6.07 - 5.33 - 4.23 - 1.84 1.62 5.91 10.44 13.46 16.26 19.73Table 11
Body height-related reference intervals (RIs) for central (aortic) augmentation index (cAIx) for females (n=462).
Body height (cm) 1th 2.5th 5th 10th 25th 50th 75th 90th 95th 97.5th 99th 102 - 1.63 1.21 3.82 7.03 12.82 19.86 27.47 34.76 39.32 43.40 48.27 105 - 1.07 1.71 4.27 7.40 13.02 19.83 27.18 34.20 38.60 42.52 47.20 110 - 0.36 2.34 4.80 7.80 13.17 19.65 26.61 33.25 37.40 41.09 45.50 115 0.10 2.71 5.09 7.98 13.12 19.31 25.95 32.26 36.20 39.71 43.89 120 0.32 2.85 5.15 7.93 12.88 18.83 25.19 31.24 35.01 38.37 42.36 125 0.31 2.76 4.99 7.69 12.48 18.22 24.36 30.19 33.82 37.06 40.91 130 0.09 2.48 4.64 7.26 11.92 17.50 23.46 29.12 32.64 35.78 39.52 135 - 0.32 2.01 4.12 6.68 11.22 16.67 22.49 28.02 31.47 34.53 38.19 140 - 0.90 1.37 3.44 5.95 10.40 15.75 21.47 26.91 30.30 33.32 36.91 145 - 1.63 0.60 2.62 5.09 9.47 14.75 20.40 25.78 29.14 32.13 35.69 150 - 2.48 - 0.30 1.69 4.11 8.45 13.67 19.29 24.64 27.99 30.97 34.52 155 - 3.44 - 1.31 0.65 3.04 7.34 12.54 18.14 23.49 26.84 29.83 33.40 160 - 4.48 - 2.40 - 0.47 1.89 6.16 11.35 16.96 22.34 25.71 28.72 32.31 165 - 5.57 - 3.55 - 1.66 0.68 4.92 10.11 15.75 21.18 24.58 27.63 31.27 170 - 6.70 - 4.74 - 2.89 - 0.58 3.63 8.83 14.52 20.01 23.46 26.56 30.26 175 - 7.83 - 5.95 - 4.15 - 1.88 2.31 7.53 13.28 18.84 22.36 25.51 29.29 178 - 8.49 - 6.67 - 4.90 - 2.67 1.50 6.74 12.52 18.14 21.70 24.89 28.72Figure 3 (a)
Body height specific central (aortic) augmentation index (cAIx) percentiles corresponding to male cohort (n=576) of children and adolescents (b)
Body height specific central (aortic) augmentation index (cAIx) percentiles corresponding to female cohort (n=462) of children and adolescents


## 3.1. General Characteristics of the Analyzed Population

In this research 1038 healthy subjects (576 males and 462 females) were included. In Table1 the characteristics of all children, adolescents, and young adults are summarized, discriminating values obtained for males and females. Mean age for the whole population was 15.35±3.15 years (range 5.00–21.92 y.o.) and no significant age differences were found (Table 1). In this cohort, males showed the highest body weight, body height, and BMI values (p<0.001). Also, males exhibit significant higher jugulum-symphysis distance than females (p<0.001). Mean values of pSBP and pPP obtained in males were significantly higher than those obtained in females (p<0.001); on the contrary pDBP and HR were significantly lower in males compared with females. No significant differences related to gender in terms of pMAP values were observed. Moreover, males have higher mean values of cSBP and cPP than females (p<0.05 and p<0.001, resp.). See Table 1.Table 1
Children and adolescents characteristics.
All (1038) Male (n=576) Female (n=462) p value (male versus female) MV SD Min Max MV SD Min Max MV SD Min Max Age (years) 15.35 3.15 5.00 21.92 15.51 2.84 5.00 21.75 15.15 3.49 5.17 21.92 0.068 Body height (cm) 162.67 13.98 102.00 191.00 167.15 13.72 104.00 191.00 157.09 12.20 102.00 178.00 <0.001 Body weight (Kg) 57.00 14.14 15.00 96.00 61.39 14.70 15.00 96.00 51.51 11.22 18.00 75.00 <0.001 BMI (Kg./m2) 21.17 3.11 7.90 29.40 21.60 3.14 13.60 29.40 20.64 2.98 7.90 27.82 <0.001 Jugulo -symphysis distance (cm) 47.48 4.96 28.00 74.00 49.13 4.87 28.00 74.00 45.44 4.27 28.00 56.00 <0.001 Heart rate (b.p.m.) 68.43 12.17 44.00 113.00 65.49 11.83 44.00 104.00 72.09 11.60 44.00 113.00 <0.001 Peripheral SBP (mmHg) 111.81 9.58 81.00 135.00 114.01 9.64 89.00 135.00 109.06 8.78 81.00 134.00 <0.001 Peripheral MBP (mmHg) 79.07 7.49 8.00 102.00 79.24 7.68 8.00 98.00 78.86 7.25 61.00 102.00 0.412 Peripheral DBP (mmHg) 62.71 7.51 3.00 89.00 61.97 7.17 36.00 82.00 63.63 7.84 3.00 89.00 <0.001 Peripheral PP (mmHg) 48.96 8.29 .49 86.00 51.99 8.12 31.00 86.00 45.17 6.81 .49 70.00 <0.001 Central (aortic) SBP (mmHg) 98.86 8.39 75.20 124.90 99.35 8.40 78.00 124.90 98.24 8.36 75.20 121.00 0.035 Central (aortic) PP (mmHg) 36.26 5.88 21.80 62.90 37.43 5.72 21.80 62.90 34.78 5.75 23.20 58.60 <0.001 Peripheral (brachial) AIx (%) - 1.34 7.01 - 85.00 . 60 - 1.64 8.12 - 85.00 . 29 - . 96 5.31 - 84.00 .60 0.122 cAIx (%) 9.20 8.46 - 12.00 45.90 6.67 7.40 - 7.00 36.00 12.35 8.64 - 12.00 45.90 <0.001 cAIx HR75 (%) 9.51 8.49 - 12.34 45.61 7.12 7.45 - 7.82 36.53 12.49 8.76 - 12.34 45.61 <0.001 Return time (ms) 173.47 21.17 14.00 310.00 178.91 19.43 85.00 230.00 166.68 21.32 14.00 310.00 <0.001 Ejection duration (ms) 299.06 22.73 185.00 385.00 297.90 21.09 185.00 360.00 300.49 24.59 190.00 385.00 0.068 Ao-PWV (m/s) 5.50 .63 3.40 7.70 5.51 .64 3.40 7.70 5.48 .62 3.90 7.70 0.607 BMI: body mass index. SBP, MBP, DBP, and PP: systolic, mean, diastolic, and pulse blood pressure, respectively. AIx: augmentation index. cAIx and cAIx HR75: central (aortic) augmentation index net value and normalized for heart rate equal 75 beats/minute, respectively. Ao-PWV: Aortic pulse wave velocity. Min and Max: minimal and maximal value, respectively. Ap<0.05 was considered statistically significant.Table 2
Association between aortic characteristics and anthropometric and haemodynamic parameters.
Central (aortic) SBP (mmHg) cAIx (%) Age (years) Sex (0: male; 1: female) R - . 066 . 334 - . 057 P . 035 . 000 . 068 Age (years) R . 263 - . 188 1.000 P . 000 . 000 . 000 Body height (cm) R . 238 - . 371 . 678 P . 000 . 000 . 000 Body weight (Kg) R . 318 - . 362 . 617 P . 000 . 000 . 000 BMI (Kg/m2) R . 320 - . 215 . 414 P . 000 . 000 . 000 Yugulo-symphysis distance (cm) R . 242 - . 378 . 656 P . 000 . 000 . 000 Heart rate (b.p.m.) R . 054 . 005 - . 358 P . 079 . 881 . 000 Peripheral SBP (mmHg) R . 892 - . 216 . 308 P . 000 . 000 . 000 Peripheral MBP (mmHg) R . 863 - . 016 . 293 P . 000 . 617 . 000 Peripheral DBP (mmHg) R . 720 . 107 . 236 P . 000 . 001 . 000 Peripheral PP (mmHg) R . 385 - . 336 . 131 P . 000 . 000 . 000 Central (aortic) SBP (mmHg) R 1.000 . 164 . 263 P . 000 . 000 . 000 Central (aortic) PP (mmHg) R . 525 . 180 . 040 P . 000 . 000 . 202 Peripheral (brachial) AIx R - . 018 . 079 - . 079 P . 571 . 011 . 011 cAIx (%) R . 164 1.000 - . 188 P . 000 . 000 . 000 cAIx HR75 (%) R . 162 . 997 - . 160 P . 000 . 000 . 000 Ejection duration (ms) R - . 026 . 207 . 096 P . 396 . 000 . 002 Return time (ms) R - . 118 - . 327 . 152 P . 000 . 000 . 000 Ao-PWV (m/s) R . 374 . 010 . 456 P . 000 . 757 . 000 BMI: body mass index. SBP, MBP, DBP, and PP: systolic, mean, diastolic, and pulse blood pressure, respectively. AIx: augmentation index. cAIx and cAIx HR75: central (aortic) augmentation index net value and normalized for heart rate equal 75 beats/minute, respectively. Ao-PWV: aortic pulse wave velocity. Ap<0.05 was considered statistically significant.Table 3
Sex-related cSBP and cAIx comparison: analysis of covariance (ANCOVA) adjusting by age, heart rate, and/or anthropometric variables (cofactors).
(a) cSBP (mMHg): before adjustment cSBP (mmHg): after adjustment by covariates Covariates appearing in the model are evaluated at the following values Levene’s test Homogeneity of regression slopes test AdjustedR2 MV SD p MV SE 95% CI lower bound 95% CI upper bound p Age (years) Body height (cm) Body weight (Kg) Yugulo-Symphysis distance (cm) Heart rate (b.p.m.) Model 1 Male 99.3517 8.39824 <0.001 99.241 .337 98.579 99.903 0.090 15.35 ------ ------ ------ ------ 0.773 0.002 0.070 Female 98.2448 8.35555 98.383 .377 97.643 99.122 Model 2 Male 99.3517 8.39824 <0.001 98.813 .350 98.125 99.500 0.852 15.35 162.67 57.00 47.48 ------ 0.797 0.011 0.113 Female 98.2448 8.35555 98.917 .397 98.139 99.696 Model 3 Male 99.3517 8.39824 <0.001 99.616 .337 98.954 100.278 0.724 15.35 ------ ------ ------ 68.43 0.724 0.001 0.101 Female 98.2448 8.35555 97.916 .378 97.173 98.658 Model 4 Male 99.3517 8.39824 <0.001 99.061 .345 98.385 99.737 0.415 15.35 162.67 57.00 47.48 68.43 0.859 0.005 0.151 Female 98.2448 8.35555 98.607 .391 97.841 99.374  (b) cAIx: before adjustment cAIx: after adjustment by covariates Covariates appearing in the model are evaluated at the following values Levene’s test Homogeneity of regression slopes test AdjustedR2 MV SD p MV SE 95% CI lower bound 95% CI upper bound p Age (years) Body Height (cm) Body weight (Kg) Yugulo-Symphysis distance (cm) Heart rate (b.p.m.) Model 1 Male 6.6737 7.40231 <0.001 6.747 .327 6.104 7.389 <0.001 15.35 ------ ------ ------ ------ <0.001 0.228 0.138 Female 12.3474 8.64323 12.257 .366 11.539 12.974 Model 2 Male 6.6737 7.40231 <0.001 7.72 .337 7.059 8.380 <0.001 15.35 162.67 57.00 47.4846 ------ <0.001 0.158 0.193 Female 12.3474 8.64323 11.043 .381 10.295 11.792 Model 3 Male 6.6737 7.40231 <0.001 6.411 .328 5.767 7.055 <0.001 15.35 ------ ------ ------ 68.43 0.020 0.008 0.163 Female 12.3474 8.64323 12.675 .368 11.953 13.397 Model 4 Male 6.6737 7.40231 <0.001 7.447 .329 6.802 8.093 <0.001 15.35 162.67 57.00 47.4846 68.43 0.005 0.006 0.238 Female 12.3474 8.64323 11.383 .373 10.651 12.115 cSBP: central (aortic) systolic blood pressure. MV: mean value: SD and SE: standard deviation and error, respectively. CI: confidence interval. cAIx: central (aortic) augmentation index (net value). Ap<0.05 was considered statistically significant.Table 4
Age-related reference intervals (RIs) for central (aortic) systolic blood pressure for the entire population (n=1038).
Age (years) 1th 2.5th 5th 10th 25th 50th 75th 90th 95th 97.5th 99th 5.0 77.6 79.2 80.7 82.3 85.1 88.3 91.6 94.6 96.5 98.1 100.0 6.0 77.5 79.4 81.0 83.0 86.3 90.0 93.9 97.5 99.7 101.7 104.0 7.0 77.5 79.6 81.5 83.6 87.3 91.5 95.9 99.9 102.4 104.6 107.2 8.0 77.7 79.9 81.9 84.2 88.2 92.8 97.5 102.0 104.7 107.1 109.9 9.0 77.9 80.3 82.4 84.8 89.0 93.9 99.0 103.7 106.6 109.1 112.2 10.0 78.2 80.7 82.9 85.4 89.8 94.9 100.2 105.1 108.2 110.8 114.0 11.0 78.6 81.2 83.4 86.0 90.5 95.8 101.3 106.4 109.5 112.3 115.6 12.0 79.0 81.6 83.9 86.6 91.2 96.6 102.2 107.4 110.7 113.5 116.9 13.0 79.5 82.1 84.5 87.2 91.9 97.4 103.1 108.4 111.7 114.6 118.0 14.0 80.0 82.7 85.0 87.8 92.5 98.0 103.8 109.2 112.5 115.4 118.9 15.0 80.5 83.2 85.6 88.3 93.1 98.7 104.5 109.9 113.2 116.2 119.7 16.0 81.1 83.8 86.1 88.9 93.7 99.3 105.1 110.5 113.8 116.7 120.3 17.0 81.7 84.4 86.7 89.5 94.3 99.8 105.6 111.0 114.3 117.2 120.7 18.0 82.3 85.0 87.3 90.1 94.8 100.3 106.0 111.4 114.7 117.6 121.1 19.0 83.0 85.6 87.9 90.6 95.3 100.8 106.5 111.8 115.0 117.9 121.3 20.0 83.6 86.2 88.5 91.2 95.9 101.2 106.8 112.1 115.3 118.1 121.5 21.0 84.3 86.9 89.1 91.8 96.4 101.7 107.2 112.3 115.5 118.2 121.6 21.8 84.8 87.4 89.6 92.3 96.8 102.0 107.4 112.5 115.6 118.3 121.6Table 5
Age-related reference intervals (RIs) for central (aortic) systolic blood pressure for males (n=576).
Age (years) 1th 2.5th 5th 10th 25th 50th 75th 90th 95th 97.5th 99th 5.0 76.4 78.4 80.1 82.1 85.3 89.0 92.5 95.8 97.7 99.3 101.2 6.0 75.4 77.7 79.7 82.0 85.8 90.0 94.2 98.0 100.2 102.2 104.4 7.0 74.8 77.4 79.6 82.2 86.4 91.1 95.7 99.9 102.4 104.5 107.0 8.0 74.7 77.5 79.8 82.6 87.1 92.1 97.1 101.5 104.2 106.5 109.1 9.0 74.8 77.8 80.3 83.1 87.9 93.1 98.4 103.0 105.8 108.2 111.0 10.0 75.2 78.2 80.8 83.8 88.7 94.1 99.5 104.3 107.2 109.7 112.6 11.0 75.8 78.9 81.5 84.5 89.6 95.1 100.6 105.5 108.5 111.0 113.9 12.0 76.5 79.6 82.3 85.4 90.5 96.1 101.7 106.6 109.6 112.2 115.1 13.0 77.4 80.5 83.2 86.3 91.4 97.0 102.7 107.6 110.6 113.2 116.2 14.0 78.4 81.5 84.2 87.3 92.4 98.0 103.6 108.6 111.6 114.2 117.1 15.0 79.4 82.5 85.2 88.3 93.3 98.9 104.5 109.5 112.4 115.0 118.0 16.0 80.6 83.6 86.3 89.3 94.3 99.9 105.4 110.3 113.2 115.8 118.7 17.0 81.8 84.8 87.4 90.4 95.3 100.8 106.3 111.1 114.0 116.5 119.4 18.0 83.1 86.0 88.6 91.5 96.4 101.7 107.1 111.9 114.7 117.1 120.0 19.0 84.4 87.3 89.8 92.7 97.4 102.7 107.9 112.6 115.3 117.7 120.5 20.0 85.8 88.6 91.0 93.8 98.5 103.6 108.7 113.2 116.0 118.3 121.0 21.0 87.2 90.0 92.3 95.0 99.5 104.5 109.5 113.9 116.5 118.8 121.5 21.6 88.1 90.8 93.1 95.8 100.2 105.1 109.9 114.3 116.9 119.1 121.7Table 6
Age-related reference intervals (RIs) for central (aortic) systolic blood pressure for females (n=462).
Age (years) 1th 2.5th 5th 10th 25th 50th 75th 90th 95th 97.5th 99th 5.2 79.5 80.8 82.0 83.4 85.7 88.3 91.0 93.5 95.0 96.3 97.9 6.0 79.2 80.9 82.3 84.0 86.8 90.0 93.4 96.4 98.3 100.0 101.9 7.0 79.1 81.0 82.6 84.6 88.0 91.8 95.8 99.5 101.7 103.7 106.0 8.0 79.0 81.1 83.0 85.2 88.9 93.3 97.8 101.9 104.5 106.7 109.4 9.0 79.0 81.3 83.3 85.7 89.8 94.5 99.4 103.9 106.7 109.2 112.1 10.0 79.1 81.5 83.7 86.2 90.5 95.5 100.7 105.5 108.5 111.1 114.3 11.0 79.2 81.7 84.0 86.6 91.1 96.3 101.8 106.8 110.0 112.7 116.0 12.0 79.4 82.0 84.3 87.0 91.6 97.0 102.6 107.9 111.1 114.0 117.4 13.0 79.6 82.3 84.6 87.4 92.1 97.6 103.4 108.7 112.0 115.0 118.5 14.0 79.9 82.5 84.9 87.7 92.5 98.1 103.9 109.4 112.7 115.7 119.2 15.0 80.1 82.8 85.2 88.0 92.9 98.5 104.4 109.8 113.2 116.2 119.8 16.0 80.4 83.1 85.5 88.3 93.2 98.8 104.7 110.2 113.6 116.6 120.1 17.0 80.7 83.4 85.8 88.6 93.5 99.1 104.9 110.4 113.7 116.7 120.3 18.0 81.1 83.8 86.1 88.9 93.7 99.2 105.0 110.4 113.8 116.7 120.3 19.0 81.4 84.1 86.4 89.2 93.9 99.4 105.1 110.4 113.7 116.6 120.1 20.0 81.8 84.4 86.7 89.4 94.1 99.5 105.1 110.3 113.6 116.4 119.8 21.0 82.2 84.8 87.0 89.7 94.2 99.5 105.0 110.1 113.3 116.1 119.4 21.8 82.5 85.1 87.3 89.9 94.3 99.5 104.9 109.9 113.0 115.7 119.0Table 7
Age-related reference intervals (RIs) for central (aortic) augmentation index (cAIx) for the entire population (n=1038).
Age (years) 1th 2.5th 5th 10th 25th 50th 75th 90th 95th 97.5th 99th 5.0 1.8 4.5 7.1 10.2 16.0 23.3 31.4 39.4 44.5 49.1 54.7 6.0 - 0.1 2.4 4.7 7.5 12.8 19.3 26.7 34.0 38.6 42.8 48.0 7.0 - 1.5 0.8 2.9 5.5 10.3 16.4 23.3 30.0 34.3 38.3 43.0 8.0 - 2.6 - 0.5 1.5 3.9 8.5 14.2 20.6 27.0 31.1 34.8 39.4 9.0 - 3.4 - 1.5 0.4 2.7 7.0 12.5 18.7 24.8 28.7 32.3 36.6 10.0 - 4.1 - 2.3 - 0.5 1.7 5.9 11.2 17.1 23.0 26.8 30.3 34.5 11.0 - 4.7 - 2.9 - 1.2 1.0 5.0 10.1 15.9 21.7 25.4 28.8 32.9 12.0 - 5.2 - 3.4 - 1.8 0.3 4.3 9.3 15.0 20.7 24.3 27.7 31.7 13.0 - 5.6 - 3.8 - 2.2 - 0.2 3.7 8.7 14.3 19.9 23.6 26.9 30.9 14.0 - 5.9 - 4.2 - 2.6 - 0.6 3.3 8.2 13.8 19.4 23.0 26.3 30.4 15.0 - 6.1 - 4.5 - 2.9 - 0.9 2.9 7.8 13.4 19.1 22.7 26.0 30.1 16.0 - 6.4 - 4.7 - 3.2 - 1.1 2.7 7.6 13.2 18.9 22.5 25.9 30.0 17.0 - 6.6 - 4.9 - 3.4 - 1.3 2.5 7.4 13.1 18.8 22.5 25.9 30.0 18.0 - 6.7 - 5.1 - 3.5 - 1.5 2.4 7.4 13.1 18.9 22.6 26.1 30.3 19.0 - 6.8 - 5.2 - 3.6 - 1.6 2.3 7.4 13.2 19.1 22.9 26.4 30.6 20.0 - 6.9 - 5.3 - 3.7 - 1.6 2.3 7.4 13.4 19.3 23.2 26.8 31.1 21.0 - 7.0 - 5.4 - 3.8 - 1.7 2.3 7.6 13.6 19.7 23.7 27.3 31.8 21.8 - 7.1 - 5.4 - 3.8 - 1.7 2.4 7.7 13.8 20.1 24.1 27.8 32.3Table 8
Age-related reference intervals (RIs) for central (aortic) augmentation index (cAIx) for males (n=576).
Age (years) 1th 2.5th 5th 10th 25th 50th 75th 90th 95th 97.5th 99th 5.0 4.6 6.0 7.2 8.7 11.4 14.6 18.1 21.4 23.4 25.3 27.5 6.0 1.2 2.7 4.1 5.8 8.9 12.7 16.9 21.0 23.6 26.0 28.8 7.0 - 1.1 0.4 1.9 3.7 7.0 11.2 15.9 20.6 23.6 26.3 29.6 8.0 - 2.6 - 1.1 0.3 2.1 5.6 10.0 15.1 20.2 23.4 26.4 30.0 9.0 - 3.6 - 2.2 - 0.8 1.0 4.5 9.0 14.3 19.7 23.1 26.3 30.2 10.0 - 4.3 - 3.0 - 1.6 0.1 3.6 8.2 13.6 19.1 22.7 26.0 30.0 11.0 - 4.8 - 3.6 - 2.3 - 0.5 2.9 7.5 13.0 18.6 22.2 25.6 29.7 12.0 - 5.2 - 4.0 - 2.7 - 1.0 2.4 7.0 12.4 18.0 21.7 25.1 29.2 13.0 - 5.4 - 4.3 - 3.1 - 1.4 1.9 6.5 11.9 17.5 21.1 24.5 28.7 14.0 - 5.6 - 4.5 - 3.3 - 1.7 1.6 6.0 11.4 16.9 20.5 23.8 27.9 15.0 - 5.6 - 4.6 - 3.5 - 1.9 1.3 5.6 10.9 16.3 19.8 23.1 27.2 16.0 - 5.7 - 4.7 - 3.5 - 2.0 1.1 5.3 10.4 15.7 19.2 22.4 26.3 17.0 - 5.7 - 4.7 - 3.6 - 2.1 0.9 5.0 10.0 15.1 18.5 21.6 25.4 18.0 - 5.6 - 4.6 - 3.6 - 2.1 0.8 4.8 9.6 14.5 17.7 20.7 24.4 19.0 - 5.6 - 4.6 - 3.5 - 2.1 0.7 4.6 9.2 13.9 17.0 19.9 23.4 20.0 - 5.4 - 4.5 - 3.4 - 2.1 0.7 4.4 8.8 13.3 16.3 19.0 22.3 21.0 - 5.3 - 4.3 - 3.3 - 2.0 0.7 4.2 8.4 12.7 15.5 18.1 21.3 21.6 - 5.2 - 4.2 - 3.2 - 1.9 0.7 4.1 8.2 12.4 15.1 17.6 20.6Table 9
Age-related reference intervals (RIs) for central (aortic) augmentation index (cAIx) for females (n=462).
Age (years) 1th 2.5th 5th 10th 25th 50th 75th 90th 95th 97.5th 99th 5.2 3.5 6.8 9.7 13.3 19.8 27.5 35.8 43.7 48.6 53.0 58.2 6.0 1.4 4.4 7.2 10.5 16.5 23.7 31.4 38.8 43.4 47.5 52.4 7.0 - 0.5 2.2 4.8 7.8 13.4 20.1 27.3 34.1 38.4 42.3 46.8 8.0 - 1.9 0.6 3.0 5.9 11.1 17.4 24.1 30.6 34.7 38.3 42.6 9.0 - 2.9 - 0.5 1.7 4.4 9.3 15.3 21.8 28.0 31.8 35.3 39.4 10.0 - 3.7 - 1.4 0.7 3.4 8.1 13.8 20.0 25.9 29.6 33.0 36.9 11.0 - 4.2 - 2.0 0.1 2.6 7.1 12.7 18.6 24.4 28.0 31.2 35.0 12.0 - 4.5 - 2.4 - 0.4 2.0 6.4 11.8 17.7 23.2 26.7 29.9 33.6 13.0 - 4.7 - 2.7 - 0.7 1.7 6.0 11.3 17.0 22.4 25.9 28.9 32.6 14.0 - 4.8 - 2.8 - 0.9 1.5 5.7 10.9 16.5 21.9 25.2 28.3 31.9 15.0 - 4.8 - 2.8 - 0.9 1.4 5.6 10.7 16.3 21.6 24.9 27.9 31.4 16.0 - 4.8 - 2.7 - 0.8 1.5 5.6 10.7 16.2 21.4 24.7 27.7 31.2 17.0 - 4.6 - 2.6 - 0.7 1.6 5.8 10.8 16.3 21.5 24.8 27.7 31.2 18.0 - 4.4 - 2.3 - 0.5 1.9 6.0 11.0 16.5 21.7 25.0 27.9 31.4 19.0 - 4.1 - 2.0 - 0.1 2.2 6.3 11.4 16.8 22.1 25.3 28.2 31.7 20.0 - 3.7 - 1.7 0.3 2.6 6.8 11.8 17.3 22.5 25.8 28.7 32.2 21.0 - 3.3 - 1.2 0.7 3.1 7.3 12.4 17.9 23.1 26.4 29.3 32.8 21.8 - 3.0 - 0.8 1.1 3.5 7.7 12.9 18.4 23.7 27.0 29.9 33.4No significant gender differences in peripheral AIx, ejection duration, and Ao-PWV mean values were observed in the analyzed population. Obtained mean values of cAIx and cAIx-HR75 were always higher in females than in males (p<0.001). See Table 1.


## 3.2. Analysis of cSBP and cAIx Associations

As was mentioned significant differences between cAIx and cAIx-HR75 were found; however absolutely values of these differences were really minimal (mean error = −0.3167,p<0.0001; mean error 95% confidence interval = −0.3522 to −0.2811; mean error SD = 0.5836, 95% confidence interval = −1.4605 to 0.8272). Consequently, taking into account the RIs generated in terms of cAIx, it was evidenced that it was not necessary to generate RIs using cAIx-HR75 obtained values. That is to say, percentiles generated using cAIx or cAIx-HR75 were very similar and observed differences were lack of clinical relevance. In other words, the difference was not considered clinically significant, as to force the generation of RIs separately (for cAIx and cAIx-HR75).Table2 show the bivariate and point-biserial correlation study of cSBP, cAIx, and Age relationship with demographic, anthropometric, hemodynamic, and vascular parameters of the analyzed population. As can be seen in Table 2, the age and the anthropometric parameters show a positive and significantly association with cSBP and cAIx levels. Moreover, HR shows borderline statistic values of association with cSBP (p=0.079).Table3 show a covariance (ANCOVA) study destined to determine if the gender discrimination would be necessary in the RIs of cSBP and cAIx generation using data collected in this research. Also in Table 3, the noncorrected and corrected marginals’ means values with standard error and 95% confidence intervals are given for males and females. In the case of cSPB, a first analysis induces to think that adjustments using Models 1, 2, 3, and 4 show no statistically significantly gender differences. However, the comparison of regression lines obtained from males and females showed statistically significant differences; that is to say there are different slopes of the cSBP-age regression lines (see homogeneity of regression slope’s test in Table 3(a)). As the ANCOVA analysis and the associated adjusted means values rely on the assumption of the homogeneity of regression slopes in the studied groups. If this assumption is not met (p<0.05) the ANCOVA results are unreliable; consequently, in the analyzed population, it is absolutely necessary to perform different RIs for cSBP for males and females (Table 3(a)). Similar results were obtained when sex-related differences in cAIx were analyzed using Models 3 and 4 (Table 3(b)). Moreover, for all considered models, sex-related differences after Levene’s test for equality of variances were also demonstrated (different in terms of the calculated variance). Again, if Levene’s test is positive (p<0.05) the variances in the analyzed groups should be considered statistically different (the groups are not homogeneous); so the assumption of homogeneity is not met and the ANCOVA analysis is invalid. As a consequence of the results obtained in cAIx ANCOVA analysis, sex-related RIs should be necessary in this population (Table 3(b)).


## 3.3. Reference Intervals (Percentile Analysis) Obtained in the Analyzed Population

As is shown in Table4, specific percentiles of age-cSBP values for five-year age RIs were generated including the entire population (n=1038), that is, including males and females. Furthermore, a similar analysis was carried out using values corresponding to each year of age (Table A in Supplementary Materials). As seen in Table 5, age-cSBP percentiles corresponding to 5-year age intervals were generated for males (n=576). A similar analysis was done for each year of age, as seen in Table B (see Supplementary Materials). Females (n=462) were analyzed using a similar method, and the obtained RIs can be seen in Table 6 and Table C (see Supplementary Materials). Figures 1(a), 1(b), and 1(c) show specific age-cSBP percentiles for the entire population, males and females, respectively. As expected, there was a positive association between age and cSBP values, representing a gradual and continuous increase in terms of cSBP.Figure 1 (a)
Age specific central (aortic) systolic blood pressure (cSBP) percentiles generated using data of the entire population (n=1038) of children and adolescents (b)
Age specific central (aortic) systolic blood pressure (cSBP) percentiles corresponding to male cohort (n=576) of children and adolescents (c)
Age specific central (aortic) systolic blood pressure (cSBP) percentiles corresponding to female cohort (n=462) of children and adolescentsTables7, 8, and 9 show specific percentiles of age-cAIx values for five-year age RIs corresponding to the entire population, males and females, respectively. Furthermore, a similar analysis was carried out using values obtained by each year of age (Tables D, E, and F in Supplementary Materials). Figures 2(a), 2(b), and 2(c) show specific age-cAIx percentiles for the entire population, males and females, respectively. As expected, there was a correlation between age and cAIx values.Figure 2 (a)
Age specific central (aortic) augmentation index (cAIx) percentiles generated using data of the entire population (n=1038) of children and adolescents (b)
Age specific central (aortic) augmentation index (cAIx) percentiles corresponding to male cohort (n=576) of children and adolescents (c)
Age specific central (aortic) augmentation index (cAIx) percentiles corresponding to female cohort (n=462) of children and adolescentsSpecific percentile analysis of cAIx corresponding to each body height level (using 5 cm intervals) of the male cohort is shown in Table10. Also in Table G, using 1 cm interval is provided in Supplementary Materials. Furthermore, in Table 11 and Table H of the Supplementary Materials, RIs corresponding to the female cohort are showed. Figures 3(a) and 3(b) show body height-cAIx percentiles, corresponding to males and females, respectively.Table 10
Body height-related reference intervals (RIs) for central (aortic) augmentation index (cAIx) for males (n=576).
Body height (cm) 1th 2.5th 5th 10th 25th 50th 75th 90th 95th 97.5th 99th 104 5.06 6.36 7.54 8.95 11.43 14.41 17.59 20.62 22.51 24.20 26.23 105 4.79 6.12 7.32 8.76 11.31 14.35 17.62 20.74 22.69 24.44 26.52 110 3.54 4.97 6.26 7.83 10.64 14.03 17.70 21.23 23.45 25.44 27.83 115 2.38 3.87 5.24 6.91 9.93 13.61 17.63 21.52 23.98 26.19 28.85 120 1.31 2.85 4.26 6.01 9.18 13.10 17.41 21.61 24.28 26.69 29.59 125 0.33 1.88 3.33 5.12 8.41 12.52 17.07 21.54 24.39 26.96 30.08 130 - 0.58 0.97 2.43 4.25 7.62 11.87 16.62 21.31 24.31 27.03 30.32 135 - 1.41 0.11 1.57 3.40 6.82 11.17 16.07 20.93 24.06 26.89 30.33 140 - 2.18 - 0.69 0.75 2.57 6.01 10.42 15.43 20.43 23.65 26.58 30.14 145 - 2.88 - 1.44 - 0.03 1.76 5.19 9.63 14.71 19.80 23.09 26.09 29.75 150 - 3.51 - 2.13 - 0.77 0.99 4.37 8.81 13.91 19.07 22.41 25.46 29.18 155 - 4.09 - 2.78 - 1.48 0.23 3.56 7.96 13.06 18.24 21.61 24.69 28.46 160 - 4.61 - 3.38 - 2.14 - 0.49 2.76 7.09 12.16 17.33 20.70 23.79 27.58 165 - 5.07 - 3.93 - 2.76 - 1.18 1.96 6.21 11.21 16.34 19.70 22.79 26.57 170 - 5.49 - 4.44 - 3.34 - 1.84 1.19 5.32 10.23 15.30 18.62 21.68 25.44 175 - 5.85 - 4.90 - 3.88 - 2.47 0.43 4.43 9.23 14.20 17.47 20.50 24.21 180 - 6.16 - 5.31 - 4.38 - 3.06 - 0.31 3.54 8.20 13.06 16.27 19.24 22.89 185 - 6.42 - 5.68 - 4.83 - 3.61 - 1.02 2.66 7.16 11.88 15.02 17.91 21.50 190 - 6.63 - 6.01 - 5.25 - 4.13 - 1.71 1.80 6.12 10.68 13.72 16.54 20.03 191 - 6.67 - 6.07 - 5.33 - 4.23 - 1.84 1.62 5.91 10.44 13.46 16.26 19.73Table 11
Body height-related reference intervals (RIs) for central (aortic) augmentation index (cAIx) for females (n=462).
Body height (cm) 1th 2.5th 5th 10th 25th 50th 75th 90th 95th 97.5th 99th 102 - 1.63 1.21 3.82 7.03 12.82 19.86 27.47 34.76 39.32 43.40 48.27 105 - 1.07 1.71 4.27 7.40 13.02 19.83 27.18 34.20 38.60 42.52 47.20 110 - 0.36 2.34 4.80 7.80 13.17 19.65 26.61 33.25 37.40 41.09 45.50 115 0.10 2.71 5.09 7.98 13.12 19.31 25.95 32.26 36.20 39.71 43.89 120 0.32 2.85 5.15 7.93 12.88 18.83 25.19 31.24 35.01 38.37 42.36 125 0.31 2.76 4.99 7.69 12.48 18.22 24.36 30.19 33.82 37.06 40.91 130 0.09 2.48 4.64 7.26 11.92 17.50 23.46 29.12 32.64 35.78 39.52 135 - 0.32 2.01 4.12 6.68 11.22 16.67 22.49 28.02 31.47 34.53 38.19 140 - 0.90 1.37 3.44 5.95 10.40 15.75 21.47 26.91 30.30 33.32 36.91 145 - 1.63 0.60 2.62 5.09 9.47 14.75 20.40 25.78 29.14 32.13 35.69 150 - 2.48 - 0.30 1.69 4.11 8.45 13.67 19.29 24.64 27.99 30.97 34.52 155 - 3.44 - 1.31 0.65 3.04 7.34 12.54 18.14 23.49 26.84 29.83 33.40 160 - 4.48 - 2.40 - 0.47 1.89 6.16 11.35 16.96 22.34 25.71 28.72 32.31 165 - 5.57 - 3.55 - 1.66 0.68 4.92 10.11 15.75 21.18 24.58 27.63 31.27 170 - 6.70 - 4.74 - 2.89 - 0.58 3.63 8.83 14.52 20.01 23.46 26.56 30.26 175 - 7.83 - 5.95 - 4.15 - 1.88 2.31 7.53 13.28 18.84 22.36 25.51 29.29 178 - 8.49 - 6.67 - 4.90 - 2.67 1.50 6.74 12.52 18.14 21.70 24.89 28.72Figure 3 (a)
Body height specific central (aortic) augmentation index (cAIx) percentiles corresponding to male cohort (n=576) of children and adolescents (b)
Body height specific central (aortic) augmentation index (cAIx) percentiles corresponding to female cohort (n=462) of children and adolescents


## 4. Discussion

This research provides the first Latin American database concerning RIs of cSBP and cAIx obtained on a large cohort of healthy children, adolescents, and young adults aged between 5 and 22 years. Moreover, the definition of RIs generated in this study will further improve our ability to identify young populations at high risk and represent a first step toward new approaches in the diagnosis and management of high BP states and/or other altered haemodynamic conditions found in childhood and adolescence. To the best of our knowledge, there are no widely accepted clear cutoff values for central aortic BP levels in pediatric clinical practice, in spite of recent efforts of European researchers [18]. In this context, our study provides percentiles for cSBP and cAIx representing a novel approach to optimize risk stratification in youths.The cAIx inform about the arterial wave reflection component of the left ventricular afterload. Values of cAIx are mainly determined by two factors: (a) aortic stiffness (which in turn determines the “central to peripheral” and “peripheral to central” forward and backward wave components propagation velocities) and (b) distance between aortic root and major wave reflection sites (i.e., aortic bifurcation at the level of pelvic arteries and include small arteries) [30]. Increases in aortic stiffness enhance the speed of wave reflection (resulting in an earlier return of the reflected wave to the ascending aorta) and increase the magnitude of the backward or reflected wave (resulting in an increase in aortic pulse pressure and left ventricle afterload). As a result, frequently when the AS increases the higher the cAIx is [30]. Consequently, the cAIx inform about the vascular wall state as a surrogate index of AS [6, 23]. Additionally, reduced body height is associated with early arrival of reflected waves to the ascending aorta, and consequently is associated with increased cAIx. Furthermore, high cAIx values implicate that increases of cSBP and/or cPP are determined by early arrival of reflected waves (during left ventricular systolic period). In other words, jointly analyzing the cAIx and cSBP or cPP, it is possible to determine if the levels of cSBP or cPP (i.e., increased) are due (or not) to an increase in the amplitude or early arrival of the reflected waves. Taking into account the determinant of cAIx, subjects with similar levels of aortic stiffness could exhibit significant differences in cAIx associated with differences in body height. This is particularly important in children and adolescents in which both AS and body height are continuously changing. From this point of view, cAIx would be a very representative index of arterial dynamics and left ventricular afterload, since it evaluates simultaneously AS and changes associated with growth process.On the other hand, levels of BP are mainly determined by cardiac and vascular factors. Higher (and faster) left ventricular stroke volume is associated with high levels of cSBP and cPP. Otherwise, AS and arrival time and amplitude of wave reflections are the main determinants of cSBP and cPP, while peripheral vascular resistances and cardiac output are the main determinants of MBP and cDBP. In this context, it is important to emphasize that simultaneous measurements of central (aortic) BP and cAIx (using a single device) in children and adolescents allow us not only to know if cSBP and cPP are within physiological levels, but also in case of abnormal values to realize if they were associated or not with increased wave reflection levels (cAIx) [31, 32].Our data shows that, in agreement with the two largest data bases of cSBP measurement in children and adolescents with oscillometric techniques, males exhibit higher values of SBP and PP in both central and peripheral arteries [17, 18]. Despite the methodological differences (inclusion and exclusion criteria) in addition to the different devices used between the three studies (see Table 12), it is possible to attempt to compare the cSBP values between our data with the RIs from Hungarian [17] and German pediatric population [18] (Figure 4). In the analyzed population, the 50th percentile corresponding to boys and girls aged between 5 and 22 years shows cSBP values slightly lower than those found by Hidvégi in the Hungarian population using the same technology. Those observations were also valid in boys when 95th percentile was analyzed. However, in girls aged 10 to 17 years, these differences tend to disappear when considering the 95th percentile. On the other hand, in comparison with German database (Mobil-O-Graph System), our data shows that cSBP values in the 50th and the 95th percentiles (both sexes) were slightly higher in children below 10 years, and significantly lower in adolescents over 13 years old than those found by Elmenhorst et al. [18].Table 12
Subjects characteristics described for Europeans (Germany and Hungary) and our studied populations.
Elmenhorst et al. 2015 Hidvégi et al. 2015 Díaz et al. (our work) (1) Characteristics of the sample Number of subjects 1445 (females: 715; males: 730) 4619 (females: 2130; males: 2489) 1038 (females: 462; males: 576) Subjects precedence Living in Germany (Munich) Living in Hungary Living in Argentina (Tandil) Age interval 8–22 years 3–18 years 5–21 years Recruitment strategy Prospective (school-based setting) Prospective (nursery, elementary, and secondary schools) Prospective (nursery, elementary, and secondary schools) Communities Urban/rural ------- Urban/rural Inclusion criteria Absence of known CV; even if treated Apparently healthy; Caucasian; without medication Asymptomatic. (1) None had history of CV, pulmonary, or renal disease; (2) normal brachial BP at the time of examination; (3) none were taking medications, (4) all had normal levels of glycaemia, cholesterol, and triglycerides Exclusion criteria Hypertensive BP (<18 years: according to guideline; ≥18 years: 140/90 mmHg); obesity BMI: 3th–97th percentile; SBP and DBP: 5th–95th percentile Current and past smokers, diabetic, obese subjects, hypertensive subjects or subjects with averaged high brachial BP levels at the time of the study were excluded  (2) Aortic BP levels and waveform measurement Device Mobil-O-Graph, I.E.M., Stolberg, Germany Arteriograph, TensioMed Ltd., Budapest, Hungary Arteriograph, TensioMed Ltd., Budapest, Hungary Measurement conditions Supine position after at least 5–10 min of rest Supine position after 2-3 minutes of rest Supine position after at least 10 min of rest   (3) Characteristics of the subjects MV SD MV SD MV SD  Female Age (years) 13.8 2.9 10.5 4.8 15.1 3.5 Body height (cm) 157.0 11.6 142.7 22.4 157.1 12.2 Body weight (Kg) 48.8 12.5 37.8 15.6 51.5 11.2 BMI (Kg/m2) 19.5 3.2 17.4 2.5 20.6 3.0 pSBP (mmHg) 113.5 7.5 110.9 6.0 109.1 8.8 pDBP (mmHg) 66.0 6.8 64.7 3.0 63.6 7.8 pMBP (mmHg) 81.8 6.2 80.2 3.9 78.9 7.3 cSBP (mmHg) 100.5 8.0 100.3 3.3 98.2 8.4 Ao-PWV (m/s) 4.6 0.3 --- --- 5.5 0.6 Heart rate (b.p.m.) --- --- 82.6 7.5 72.1 11.6 Yugulo-Symphysis distance (cm) --- --- 42.0 6.6 45.4 4.3 cAIx (%) --- --- 11.9 4.4 12.3 8.6 Male Age (years) 13.1 2.6 10.5 4.8 15.5 2.8 Body height (cm) 158.7 15.6 146.3 25.7 167.2 13.7 Body weight (Kg) 49.1 15.2 40.5 18.5 61.4 14.7 BMI (Kg/m2) 19.0 3.1 17.6 2.4 21.6 3.1 pSBP (mmHg) 114.5 8.3 113.3 8.4 114.0 9.6 pDBP (mmHg) 65.1 6.8 64.7 2.6 62.0 7.2 pMBP (mmHg) 81.6 6.3 81.1 4.3 79.2 7.7 cSBP (mmHg) 100.8 9.7 101.2 4.8 99.4 8.4 Ao-PWV (m/s) 4.7 0.4   5.5 0.6 Heart rate (b.p.m.) --- --- 79.1 8.7 65.5 11.8 Yugulo-Symphysis distance (cm) --- --- 43.9 7.6 49.1 4.9 cAIx (%) --- --- 10.2 4.5 6.7 7.4 All Age (years) 13.4 2.8 --- --- 15.3 3.1 Body height (cm) ---- ---- --- --- 162.7 14.0 Body weight (Kg) ---- ---- --- --- 57.0 14.1 pSBP (mmHg) 114.0 7.9 --- --- 111.8 9.6 cSBP (mmHg) 100.7 8.9 --- --- 98.9 8.4 Ao-PWV (m/s) 4.7 0.3 --- --- 5.5 0.6 BMI: body mass index. pSBP, pMBP, and pDBP: peripheral (brachial) systolic, mean, and diastolic blood pressure, respectively. cAIx: central (aortic) augmentation index. Ao-PWV: aortic pulse wave velocity. CV: cardiovascular. MV: mean value. SD: standard deviation. cSBP: central (aortic) systolic blood pressure, respectively. Data from [18] were directly obtained from average population values published in their manuscript. Data from [17] were obtained from averaging the disaggregated values per year of life (age), for each sex.Figure 4
Age specific aortic systolic blood pressure (cSBP) percentiles 95th and 50th obtained in males and females of the Argentinean population compared with European date previously reported.On the other hand, values of cAIx show a different behavior with respect to age and gender. As was describe above, our data show that females have higher cAIx values than males (Table1). These findings are in accordance with the published data of Hidvégi et al. who proved that after 15 years the AIx is higher in females than in males [17]. These authors reported that, in early childhood, the values of AIx are high; however it decreases gradually with age in both genders in ages between 12 and 15 years, increasing afterwards. Moreover, the increased cAIx detected in early childhood cannot be caused by the shorter return time, which is determined by a shorter aortic length [17]. In Figure 5, we compared cAIx percentiles 50th and 75th corresponding ton males and females of the Argentinean population, with those reported by Hidvégi et al. [17]. It is noteworthy that females of both populations exhibit similar cAIx curves, while Argentinean males have lower values than the European cohort before 12 y.o. and higher after ages over 13 y.o.Figure 5
Age specific central (aortic) augmentation index (cAIx) percentiles 75th and 50th obtained in males and females of the Argentinean population compared with Hidvégi et al.’s date previously reported.


### 4.1. Methodological Considerations and Limitations

In this observational study a noninvasive occlusive-oscillometric device to assess arterial function parameters in children and adolescents was used. This validated system provides central aortic BP values that have shown significant correlation with values of cSBP invasively assessed [6, 23]. On the other hand, the use of an arm cuff facilitates epidemiological studies performed in large cohort including children and adolescents [14, 17, 33]. Moreover, the Arteriograph device allows simultaneous quantification of Ao-PWV, AIx, cSBP, and peripheral BP, and the procedure takes only 2-3 min and is well tolerated even in preschool children who experienced only a little discomfort, similar to that observed during noninvasive BP measurement [14].The lack of standardization in methodologies used to obtain RIs and/or normal values for cAIx, cSBP, and other noninvasive obtained arterial parameters makes difficult to compare different populations. In our research, we used the statistical and methodological approach described by theReference Values for Arterial Measurements Collaboration Group [27, 28]. This is not a minor point, since this strategy allows us to compare our data with other databases available around the world.In this observational study, we used a cross-sectional design; consequently, the relationship between cSBP and cAIx with age should be interpreted with caution. However, generation of these RIs should be generated taking advantage approaches like that used in this research.


## 4.1. Methodological Considerations and Limitations

In this observational study a noninvasive occlusive-oscillometric device to assess arterial function parameters in children and adolescents was used. This validated system provides central aortic BP values that have shown significant correlation with values of cSBP invasively assessed [6, 23]. On the other hand, the use of an arm cuff facilitates epidemiological studies performed in large cohort including children and adolescents [14, 17, 33]. Moreover, the Arteriograph device allows simultaneous quantification of Ao-PWV, AIx, cSBP, and peripheral BP, and the procedure takes only 2-3 min and is well tolerated even in preschool children who experienced only a little discomfort, similar to that observed during noninvasive BP measurement [14].The lack of standardization in methodologies used to obtain RIs and/or normal values for cAIx, cSBP, and other noninvasive obtained arterial parameters makes difficult to compare different populations. In our research, we used the statistical and methodological approach described by theReference Values for Arterial Measurements Collaboration Group [27, 28]. This is not a minor point, since this strategy allows us to compare our data with other databases available around the world.In this observational study, we used a cross-sectional design; consequently, the relationship between cSBP and cAIx with age should be interpreted with caution. However, generation of these RIs should be generated taking advantage approaches like that used in this research.


## 5. Conclusion

This study, performed in healthy children, adolescents, and young adults from Argentina with ages 5 to 22 y.o., provides the first RIs and percentile curves of cSBP and cAIx. Additionally, specific body height-related cAIx percentiles are reported for the analyzed population. The RIs and percentiles contribute to the knowledge of arterial dynamic evolution along the normal aging process and the interpretation of data obtained in clinical research and daily clinical practice.



---

*Source: 1469651-2018-04-23.xml*